Updated on 2026/02/25

写真a

 
OGURA SHUNICHIRO
 
Organization
School of Life Science and Technology Associate Professor
Title
Associate Professor
External link

News & Topics
  • Could a Naturally Occurring Amino Acid Lead Us to a Cure for COVID-19?

    2023/03/02

    Languages: English

      More details

    An amino acid called 5-aminolevulinic acid (ALA) might be key to reduce the expression of ACE2, a cell membrane receptor that SARS-CoV-2 uses to infect cells. New insights gained by scientists at

  • 5-アミノレブリン酸による SARS-CoV-2ウイルス受容体の発現抑制 新型コロナウイルス感染予防への新たなアプローチ

    2023/02/28

    Languages: Japanese

      More details

    要点-5-アミノレブリン酸が持つSARS-CoV-2ウイルス受容体の発現抑制効果を発見。-ヒト細胞表面でSARS-CoV-2ウイルスと結合する受容体タンパク質の発現量の低下を確認。-5-アミノレブリン酸による新型コロナウイルス感染予防効果を期待。概要

  • Improving detection of brain tumors

    2017/05/08

    Languages: English

      More details

    Scientists at Tokyo Medical and Dental University and Tokyo Institute of Technology have disclosed a mechanism explaining why some brain tumor cells escape photosensitive detection and proposed a method to increase its sensitivity.

  • 癌再発に深く関わる癌幹細胞が診断薬5-ALAによる検出を免れる特性を発見―癌の再発リスクを抑える診断・治療法の開発に期待―

    2017/02/08

    Languages: Japanese

      More details

    ポイント 癌幹細胞は癌の進展と治療抵抗性、再発に深く関与する癌の責任細胞です。悪性脳腫瘍などの手術時に頻用される光線力学診断薬5-ALAによる癌幹細胞の検出を、癌幹細胞が免れる仕組みを備えていることをマウス脳内移植実験などで明らかにしました。鉄キレート(捕捉)作用を持つ既存薬DFOと5-ALAの併用で癌幹細胞の検出が可能になることも発見し、手術時に癌幹細胞を見逃さない手法への応用が期待できます。癌幹細胞の代謝特性に影響を与える物質として鉄やヘムを明らかにしており、今後これらを標的として癌の再発リスクを抑える新たな診断・治療法の開発に道を拓くものです。

  • 熱帯熱マラリア原虫に対する 5-アミノレブリン酸と鉄の 相乗的な増殖阻害メカニズムを解明

    2013/12/06

    Languages: Japanese

      More details

    国立大学法人東京大学(東京都文京区、総長:濱田純一)と国立大学法人東京工業大学(東京都目黒区、学長:三島良直)、MRC National Institute for Medical Research(英国ロンドン、所長:Jim Smith)、SBI ファーマ株式会社(東京都港区、代表取締役執行役員 CEO:北尾吉孝)は、5-アミノレブリン酸(ALA)と 2 価の鉄が熱帯熱マラリア原虫の生育を相乗的に阻害する作用メカニズムについて 12 月 2 日発刊のThe Journal of Biochemistry に発表しました。発表のポイント◆ALA と 2 価の鉄との組み合わせによって、相乗的にマラリア原虫の生育を阻害するメカニズムの一端について解明しました。◆本成果は、多くの人たちを苦しめているマラリアを治療するための新規の医薬品の開発につながるものと期待されます。

  • Findings of Mechanism of 5-aminolevulinic Acid (5-ALA) and Iron in Synergistically Inhibiting Growth of Plasmodium Falciparum...

    2013/12/06

    Languages: English

      More details

    The University of Tokyo, a national university (main campus: Bunkyo-ku, Tokyo; President: Junichi Hamada), Tokyo Institute of Technology, a national university (main campus: Meguro-ku, Tokyo; President: Yoshinao Mishima),MRC National Institute for Medical Research (London, U.K. Director: Jim Smith), and SBI Pharmaceuticals Co., Ltd. (head office: Minato-ku, Tokyo; Representative Director and CEO: Yoshitaka Kitao; “SBI Pharmaceuticals”), presented their findings in The Journal of Biochemistry (2 December 2013) regarding the working mechanism of 5-aminolevulinic acid (5-ALA) and bivalent iron in inhibiting the growth of Plasmodium falciparum (P. falciparum) malaria parasites.

  • ALA に担がんマウスでの延命効果を発見

    2011/10/05

    Languages: Japanese

      More details

    SBI ホールディングス株式会社の子会社で 5-アミノレブリン酸(ALA)(※1)を利用した化粧品、 健康食品、医薬品の研究・開発等を行っているSBI アラプロモ株式会社(本社:東京都港区、代表取 締役執行役員CEO:北尾 吉孝、以下「SBI アラプロモ」) は国立大学法人東京工業大学(所在地: 東京都目黒区、学長:伊賀 健一)との共同研究において、ALA 投与が担がんマウスの衰弱を抑制し、 延命の効果があることを発見いたしました。 このたび、本研究結果を2011 年10 月4 日に開催された第70 回日本癌学会学術総会にて発表いた しましたのでお知らせいたします。

▼display all

Research Areas

  • Manufacturing Technology (Mechanical Engineering, Electrical and Electronic Engineering, Chemical Engineering) / Biofunction and bioprocess engineering

Education

  • Tokyo Institute of Technology   Graduate School, Division of Life Science and Engineering

    - 2001

      More details

  • Tokyo Institute of Technology   Bioscience and Biotechnology

    - 2001

      More details

    Country: Japan

    researchmap

  • Tokyo Institute of Technology   School of Bioscience and Biotechnology

    - 1997

      More details

    Country: Japan

    researchmap

Papers

  • Improving 5-Aminolevulinic acid photodynamic therapy through the modulation of iron metabolism

    Chenhan Li, Shun-ichiro Ogura

    Photodiagnosis and Photodynamic Therapy   2025.10

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.pdpdt.2025.104755

    researchmap

  • Highly malignant tumor cells accumulate less PpIX and enhanced cell dormancy increases PpIX accumulation. International journal

    Saki Kasai, Anantya Pustimbara, Ganesan Daneshwaran, Kiwamu Takahashi, Motowo Nakajima, Hideo Fukuhara, Shinkuro Yamamoto, Keiji Inoue, Shun-Ichiro Ogura

    Photodiagnosis and photodynamic therapy   53   104551 - 104551   2025.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: 5-Aminolevulinic acid photodynamic diagnosis (ALA-PDD) is a method for real-time diagnosis of cancer areas based on the specific accumulation of protoporphyrin IX (PpIX) in tumor cells following ALA administration and subsequent detection using fluorescence. However, its effectiveness is limited due to false negatives caused by tumor cells accumulating low amounts of PpIX after ALA administration. In order to increase the detection sensitivity of ALA-PDD, it is important to understand the characteristics of cells with low or high PpIX accumulation. This research sought to determine the factors affecting ALA-induced PpIX accumulation in tumor cells METHODS: Tumor cells were separated into two groups according to PpIX accumulation levels using FACS and the cellular characteristics were compared. RESULTS: The data of expression of RANKL, a tumor malignancy marker, showed that tumor cells with low PpIX accumulation are more malignant. Results also showed marked differences in PpIX efflux transporter activity and the extent to which iron atoms are being inserted into the porphyrin ring, resulting in loss of fluorescence. Interestingly, it was found tumor cells with high PpIX accumulation are in dormant state as indicated by low proliferation and suppression of glucose metabolism. CONCLUSION: Tumor cells with low PpIX accumulation are characterized as high tumor grade and low cell dormancy.

    DOI: 10.1016/j.pdpdt.2025.104551

    PubMed

    researchmap

  • Hemin Promotes Higher Effectiveness of Aminolevulinic-Photodynamic Therapy (ALA-PDT) in A549 Lung Cancer Cell Line by Interrupting ABCG2 Expression. International journal

    Anantya Pustimbara, Rahma Wirdatul Umami, Nurul Muhammad Prakoso, Anna Rozaliyani, Jamal Zaini, Astari Dwiranti, Shun-Ichiro Ogura, Anom Bowolaksono

    Medical sciences (Basel, Switzerland)   12 ( 4 )   2024.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND/OBJECTIVES: Due to concerns about drug resistance and side effects, the discovery of improved drugs for lung cancer has attracted studies to find an effective and safe treatment. Aminolevulinic acid-mediated photodynamic therapy (ALA-PDT) is a cancer treatment with minimal side effects. However, ALA-PDT effectiveness can be hindered by ABCG2 and ABCB1 transporters impeding PpIX accumulation. Combining ALA with other substances can enhance PpIX accumulation. Hemin is a potential substance due to its antitumor properties and may be involved in regulating the ABCG2 and ABCB1 expressions. METHODS: The objective of this report is to analyze the effects of administering a combination of hemin and ALA after 48 h on A549 lung cancer cells by quantifying cell viability, intracellular PpIX, and ROS accumulation, completed by ABCG2 and ABCB1 expressions. RESULTS: Our data indicate that the combination of hemin and ALA followed by photoirradiation decreased the viability of A549 cells, which was due to increased intracellular PpIX and ROS. The expression of ABCG2 mRNA was significantly decreased after ALA-hemin treatment, while the ABCB1 mRNA expression increased. This result might suggest that ABCG2 plays a greater role than ABCB1 in regulating the PpIX accumulation in A549 lung cancer cells. CONCLUSIONS: The combination of ALA and hemin followed by photoirradiation offers a promising novel treatment for lung cancer, and further evaluations of this therapy are required.

    DOI: 10.3390/medsci12040066

    PubMed

    researchmap

  • Hemin enhances the 5-aminolevulinic acid-photodynamic therapy effect through the changes of cellular iron homeostasis. International journal

    Anantya Pustimbara, Chenhan Li, Shun-Ichiro Ogura

    Photodiagnosis and photodynamic therapy   48   104253 - 104253   2024.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Photodynamic therapy (PDT) has been utilized as a promising alternative cancer treatment due to its minimum invasiveness over the years. Exogenous 5-aminolevulinic acid (ALA) triggers protoporphyrin IX (PpIX) accumulation, which happens in cancer cells. However, certain types of cancer exhibit reduced effectiveness in the PpIX accumulation mechanism. This study aimed to determine the effect of ALA-PDT combination with hemin on gastric carcinoma TMK-1 cells. METHODS: This study utilized TMK-1 gastric cancer cell line to evaluate PpIX, ROS, and Fe2+ accumulation following the administration of ALA, hemin, and a combination of ALA and hemin PDT. We also evaluate the mRNA expressions related to iron homeostasis and treatment impacts on cell viability. RESULTS: The co-addition of ALA and hemin PDT for 4 h of treatment resulted in a significant decrease in cell viability by up to 18 %. While ALA-PDT enhanced PpIX metabolism, the addition of hemin influenced both the production of reactive oxygen species (ROS) and cellular iron homeostasis by inducing Fe2+ accumulation and affecting mRNA levels of IRP, Tfr1, Ferritin, NFS1, and SDHB. CONCLUSION: These findings suggest that the addition of ALA and hemin enhances phototoxicity in TMK-1 cells. The combination of ALA and hemin with PDT induces cell death, evidenced by increased cytotoxicity properties such as PpIX and ROS, along with significant changes in TMK-1 gastric cancer iron homeostasis. Therefore, the combination of ALA and hemin could be one of the alternatives in photodynamic therapy for cancer in the future.

    DOI: 10.1016/j.pdpdt.2024.104253

    PubMed

    researchmap

  • Mangostin enhances efficacy of aminolevulinic acid-photodynamic therapy against cancer through inhibition of ABCG2 activity Reviewed

    Hung Wei Lai, Yukitaka Tani, Udomlak Sukatta, Prapassorn Rugthaworn, Asada Thepyos, Shinkuro Yamamoto, Hideo Fukuhara, Keiji Inoue, Hideya Yuasa, Hiroyuki Nakamura, Shun-ichiro Ogura

    Photodiagnosis and Photodynamic Therapy   Vol. 44   2023.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    researchmap

  • Metabolic shift towards oxidative phosphorylation reduces cell-density-induced cancer-stem-cell-like characteristics in prostate cancer in vitro Reviewed

    Hung Wei Lai, Moe Kasai, Shinkuro Yamamoto, Hideo Fukuhara, Takashi Karashima, Atsuhi Kurabayashi, Mutsuo Furihata, Kazuhiro Hanazaki, Keiji Inoue, Shun-ichiro Ogura

    Biology Open   Vol. 12   2023.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1242/bio.059615

    researchmap

  • Cell senescence-associated porphyrin metabolism affects the efficacy of aminolevulinic acid-photodynamic diagnosis in bladder cancer Reviewed

    Hung Wei Lai, Shinkuro Yamamoto, Hideo Fukuhara, Shun-ichiro Ogura, Keiji Inoue

    Photodiagnosis and Photodynamic Therapy   Vol. 42   2023.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    researchmap

  • Suppression of angiotensin converting enzyme 2, a host receptor for SARS-CoV-2 infection, using 5-aminolevulinic acid in vitro Reviewed

    Eriko Nara, Hung Wei Lai, Hideo Imazato, Masahiro Ishizuka, Motowo Nakajima, Shun-Ichiro Ogura

    Plos ONE   Vol. 18 ( No. 2 )   2023.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1371/journal.pone.0281399

    researchmap

  • Polymeric iron chelators for enhancing 5-aminolevulinic acid-induced photodynamic therapy Reviewed

    Takahiro Nomoto, Kana Komoto, Tomoya Nagano, Takuya Ishii, Haochen Guo, Yuto Honda, Shun-ichiro OGURA, Masahiro Ishizuka, Nobuhiro Nishiyama

    Cancer Sci.   Vol. 114 ( No. 3 )   2022.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/cas.15637

    researchmap

  • 5-アミノレブリン酸を用いた休眠がん細胞を標的とする光線力学療法

    小倉俊一郎, 中山沢, 山本新九郎, 福原秀雄, 花﨑和弘, 井上啓史

    日本レーザー医学会誌   Vol. 43 ( No. 4 )   2022.11

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)  

    DOI: 10.2530/jslsm.jslsm-43_0038

    researchmap

  • 5-aminolevulinic acid and sodium ferrous citrate decreased cell viability of gastric cancer cells by enhanced ROS generation through improving COX activity Reviewed

    Arif Suprihadi, Anantya Pustimbara, Shun-ichiro Ogura

    Photodiagnosis and Photodynamic Therapy   Vol. 40   2022.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.pdpdt.2022.103055

    researchmap

  • 4'-Nitrobiphenyl thioglucoside as the Smallest, fluorescent photosensitizer with cancer targeting ligand Reviewed

    Takashi Kanamori, Yuto Miki, Masataka Katou, Shun-ichiro Ogura, Hideya Yuasa

    Bioorganic Medicinal Chemistry   Vol. 61   2022.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.bmc.2022.116737

    researchmap

  • Current status of photodynamic technology for urothelial cancer. Reviewed International journal

    Keiji Inoue, Hideo Fukuhara, Shinkuro Yamamoto, Takashi Karashima, Atsushi Kurabayashi, Mutsuo Furihata, Kazuhiro Hanazaki, Hung Wei Lai, Shun-Ichiro Ogura

    Cancer science   113 ( 2 )   392 - 398   2022.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    5-Aminolevulinic acid is a new-generation photosensitizer with high tumor specificity. It has been used successfully in the diagnosis, treatment, and screening of urological cancers including bladder cancer; specifically, it has been used in photodynamic diagnosis to detect tumors by illuminating the lesion with a specific wavelength of light to produce fluorescence in the lesion after administration of 5-aminolevulinic acid, in photodynamic therapy, which induces tumor cell death via production of cytotoxic reactive oxygen species, and in photodynamic screening, in which porphyrin excretion in the blood and urine is used as a tumor biomarker after administration of 5-aminolevulinic acid. In addition to these applications in urological cancers, 5-aminolevulinic acid-based photodynamic technology is expected to be used as a novel strategy for a large number of cancer types because it is based on a property of cancer cells known as the Warburg effect, which is a basic biological property that is common across all cancers.

    DOI: 10.1111/cas.15193

    PubMed

    researchmap

  • Association of 5-aminolevulinic acid with intraoperative hypotension in malignant glioma surgery Reviewed

    Shumpei Morisawa, Kohei Jobu, Tomoaki Ishida, Kei Kawada, Hitoshi Fukuda, Yu Kawanishi, Taku Nakayama, Shinkuro Yamamoto, Naohisa Tamura, Mitsuhiro Takemura, Nao Kagimoto, Tsuyoshi Ohta, Noritaka Masahira, Hideo Fukuhara, Shun-ichiro Ogura, Tetsuya Ueba, Keiji Inoue, Mitsuhiko Miyamura

    Photodiagnosis and Photodynamic Therapy   Vol. 37   2021.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    researchmap

  • Predictors of therapeutic efficacy of 5-aminolevulinic acid-based photodynamic therapy in human prostate cancer Reviewed

    Shinkuro Yamamoto, Hideo Fukuhara, Hitomi Seki, Chiaki Kawada, Taku Nakayama, Takashi Karashima, Shun-Ichiro Ogura, Keiji Inoue

    Photodiagnosis and Photodynamic Therapy   Vol. 35   2021.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    researchmap

  • Sunitinib with photoirradiation-mediated reactive oxygen species generation induces apoptosis of renal cell carcinoma cells Reviewed

    Shinkuro Yamamoto, Taku Nakayama, Hitomi Seki, Chiaki Kawada, Hideo Fukuhara, Takashi Karashima, Shun-Ichiro Ogura, Keiji Inoue

    Photodiagnosis and Photodynamic Therapy   Vol. 35   2021.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.pdpdt.2021.102427

    researchmap

  • Efficiency of aminolevulinic acid (ALA)-photodynamic therapy based on ALA uptake transporters in a cell density-dependent malignancy model Reviewed

    Hung Wei Lai, Kiwamu Takahashi, Motowo Nakajima, Tohru Tanaka, Shun-ichiro Ogura

    Journal of Photochemistry and Photobiology B: Biology   Vol. 218   2021.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    researchmap

  • Enhanced lipid metabolism induces the sensitivity of dormant cancer cells to 5-aminolevulinic acid-based photodynamic therapy Reviewed

    Taku Nakayama, Tomonori Sano, Yoshiki Oshimo, Chiaki Kawada, Moe Kasai, Shinkuro Yamamoto, Hideo Fukuhara, Keiji Inoue, Shun-ichiro Ogura

    Scientific Reports   Vol. 11   2021.4

     More details

    Authorship:Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    researchmap

  • Key transporters leading to specific protoporphyrin IX accumulation in cancer cell following administration of aminolevulinic acid in photodynamic therapy/diagnosis

    Hung Wei Lai, Taku Nakayama, Shun-ichiro Ogura

    International Journal of Clinical Oncology   2021.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s10147-020-01766-y

    researchmap

  • Mitomycin C-induced cell cycle arrest enhances 5-aminolevulinic acid-based photodynamic therapy for bladder cancer

    Taku Nakayama, Naoko Nozawa, Chiaki Kawada, Shinkuro Yamamoto, Takuya Ishii, Masahiro Ishizuka, Tsutomu Namikawa, Shun-ichiro Ogura, Kazuhiro Hanazaki, Keiji Inoue, Takashi Karashima

    Photodiagnosis and Photodynamic Therapy   Vol. 31   2020.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    researchmap

  • Photoirradiation after aminolevulinic acid treatment suppresses cancer cell proliferation through the HO-1/p21 pathway

    Taku Nakayama, Tatsuya Kobayashi, Otsuka Shinpei, Hideo Fukuhara, Tsutomu Namikawa, Keiji Inoue, Kazuhiro Hanazaki, Kiwamu Takahashi, Motowo Nakajima, Tohru Tanaka, Shun-ichiro Ogura

    Photodiagnosis and photodynamic therapy   Vol. 28   2019.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    researchmap

  • Inverse correlation between heme synthesis and the Warburg effect in cancer cells

    Yuta Sugiyama, Erika Takahashi, Kiwamu Takahashi, Motowo Nakajima, Tohru Tanaka, Shun-ichiro Ogura

    2019.8

     More details

  • A Twist‐Assisted Biphenyl Photosensitizer Passable Through Glucose Channel

    Yuki Tsuga, Masataka Katou, Satoshi Kuwabara, Takashi Kanamori, Shun-ichiro Ogura, Shigetoshi Okazaki, HiroyukiI Ohtani, Hideya Yuasa

    Chemistry – An Asian Journal   Vol. 14   2019.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1002/asia.201900378

    researchmap

  • Novel Strategy to Increase Specificity of ALA-Induced PpIX Accumulation through Inhibition of Transporters Involved in ALA Uptake

    Hung Wei Lai, Ryuta Sasaki, Shiro Usuki, Motowo Nakajima, Tohru Tanaka, Shun-ichiro Ogura

    Photodiagnosis and photodynamic therapy   Vol. 27   2019.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    researchmap

  • 5-Aminolevulinic acid regulates the immune response in LPS-stimulated RAW 264.7 macrophages

    Yuta Sugiyama, Yukari Hiraiwa, Yuichiro Hagiya, Motowo Nakajima, Tohru Tanaka, Shun-ichiro Ogura

    BMC Immunology   Vol. 19   2018.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1186/s12865-018-0277-5

    researchmap

  • Water-Soluble Glucosyl Pyrene Photosensitizers: An Intramolecularly Synthesized 2- C-Glucoside and an O-Glucoside. International journal

    Takashi Kanamori, Akira Matsuyama, Hidenori Naito, Yuki Tsuga, Yoshiki Ozako, Shun-Ichiro Ogura, Shigetoshi Okazaki, Hideya Yuasa

    The Journal of organic chemistry   83 ( 22 )   13765 - 13775   2018.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Prevalent photosensitizing agents for photodynamic therapy (PDT) suffer from their relatively large molecular weights causing photodermatosis. In this regard, low molecular weight pyrene could be an efficient photosensitizer except for its extreme hydrophobicity. To tackle the insolubility of pyrene, we synthesized 1-carboxypyren-2-yl C-glucoside 4 by a tethered C-glucosylation and 1-pyrenylmethyl O-glucoside 5 by a simple O-glucosylation. Compounds 4 and 5 showed modest water solubilities of 72 and 47 μg/mL, respectively. Whereas compound 4 partially underwent a cyclization reaction at pH 3 to give the corresponding δ-valerolactone 15b in 31% yield after 24 h, it is stable at pH 5-9 for at least a week. The 1O2-producing photosensitizabilities of 4 and 5 were sufficient to apply to PDT. Although compound 5 was uptaken by HeLa cells and showed a good PDT activity, compound 4 showed neither a sufficient cell uptake nor PDT effect. The binding modes of compounds 4 and 5 to concanavalin A were specific and unspecific, respectively. These results demonstrate that compounds 4 and 5 are within a pharmacologically acceptable range as oral drugs and could be a fluorescence imaging probe for α-glucose/mannose receptors and a photosensitizing agent for PDT, respectively.

    DOI: 10.1021/acs.joc.8b02066

    PubMed

    researchmap

  • Synthesis and crystal structures of phenylalanine ester-introduced palladium(II) and platinum(II) complexes and their cytotoxicities

    Akihiro Nomoto, Nozomi Sakamoto, Yuta Sakai, Keisuke Fukumoto, Shun-ichiro Ogura, Karao Shouhei, Kiyomi Kakiuchi, Jun-ichi Kikuchi, Shigenobu Yano, Akiya Ogawa

    Research on Chemical Intermediates   2018.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s11164-018-3623-6

    researchmap

  • Development of a novel Schiff base derivative for enhancing the anticancer potential of 5-aminolevulinic acid-based photodynamic therapy. International journal

    Yusei Shinohara, Yoshio Endo, Chiaki Abe, Ikkyu Shiba, Masahiro Ishizuka, Tohru Tanaka, Yutaka Yonemura, Shun-Ichiro Ogura, Masahide Tominaga, Hisatsugu Yamada, Yoshihiro Uto

    Photodiagnosis and photodynamic therapy   20 ( 182-188 )   182 - 188   2017.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    5-Aminolevulinic acid (ALA), a precursor of protoporphyrin IX (PpIX), is now widely used for photodynamic diagnosis (ALA-PDD) and photodynamic therapy (ALA-PDT) of various cancers. Recently, we found that treatment of cancer cells with the Schiff base derivative TX-816 along with ALA could significantly increase the efficacy of ALA-PDT. This enhancing effect of TX-816 on ALA-PDT is attributed to 3,5-dichlorosalicylaldehyde (DCSA), a molecule produced by the degradation of TX-816. Similar to TX-816, DCSA significantly enhances the effect of ALA-PDT. Furthermore, DCSA could restore the sensitivity of cancer cells that acquired resistance to ALA-PDT. These results indicate that DCSA, as well as TX-816, is a potent lead compound for the development of an ALA-PDT sensitizer. TX-816 might be a useful compound for designing prodrug-type ALA-PDT enhancers.

    DOI: 10.1016/j.pdpdt.2017.10.014

    PubMed

    researchmap

  • Photodynamic Detection of Peritoneal Metastases Using 5-Aminolevulinic Acid (ALA). International journal

    Yutaka Yonemura, Yoshio Endo, Emel Canbay, Yang Liu, Haruaki Ishibashi, Akiyoshi Mizumoto, Masamitu Hirano, Yuuki Imazato, Nobuyuki Takao, Masumi Ichinose, Kousuke Noguchi, Yan Li, Satoshi Wakama, Kazuhiro Yamada, Koutarou Hatano, Hiroshi Shintani, Hiroyuki Yoshitake, Shun-Ichiro Ogura

    Cancers   9 ( 3 )   2017.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    In the past, peritoneal metastasis (PM) was considered as a terminal stage of cancer. From the early 1990s, however, a new comprehensive treatment consisting of cytoreductive surgery and perioperative chemotherapy has been established to improve long-term survival for selected patients with PM. Among prognostic indicators after the treatment, completeness of cytoreduction is the most independent predictors of survival. However, peritoneal recurrence is a main cause of recurrence, even after complete cytoreduction. As a cause of peritoneal recurrence, small PM may be overlooked at the time of cytoreductive surgery (CRS), therefore, development of a new method to detect small PM is desired. Recently, photodynamic diagnosis (PDD) was developed for detection of PM. The objectives of this review were to evaluate whether PDD using 5-aminolevulinic acid (ALA) could improve detection of small PM.

    DOI: 10.3390/cancers9030023

    PubMed

    researchmap

  • Improving contrast enhancement in magnetic resonance imaging using 5-aminolevulinic acid-induced protoporphyrin IX for high-grade gliomas. International journal

    Junkoh Yamamoto, Shingo Kakeda, Tetsuya Yoneda, Shun-Ichiro Ogura, Shohei Shimajiri, Tohru Tanaka, Yukunori Korogi, Shigeru Nishizawa

    Oncology letters   13 ( 3 )   1269 - 1275   2017.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Magnetic resonance imaging (MRI) with a gadolinium-based contrast agent is the gold standard for high-grade gliomas (HGGs). The compound 5-aminolevulinic acid (5-ALA) undergoes a high rate of cellular uptake, particularly in cancer cells. In addition, fluorescence-guided resection with 5-ALA is widely used for imaging HGGs. 5-ALA is water soluble, while protoporphyrin IX (PpIX) is water insoluble. It was speculated whether converting from 5-ALA to PpIX may relatively increase intracellular water content, and consequently, might enhance the T2 signal intensity in HGG. The aim of the present study was to assess whether 5-ALA-induced PpIX enhances the T2 signal intensity in patients with HGGs. A total of 4 patients who were candidates for HGG surgical treatment were prospectively analyzed with preoperative MRI. Patients received oral doses of 5-ALA (20 mg/kg) 3 h prior to anesthesia. At 2.5 h post-5-ALA administration, T2-weighted images (T2WIs) were obtained from all patients. Subsequently, tumors were evaluated via fluorescence using a modified operating microscope. Fluorescent tumor tissues were obtained to analyze the accumulation of 5-ALA-induced PpIX within the tumors, which was confirmed quantitatively by high-performance liquid chromatography (HPLC) analysis. The MRI T2 signal intensity within the tumors was evaluated prior to and following 5-ALA administration. Three glioblastoma multiformes (GBMs) and 1 anaplastic oligodendroglioma (AO) were included in the analysis. Intraoperatively, all GBMs exhibited strong fluorescence of 5-ALA-induced PpIX, whilst no fluorescence was observed in the AO sample. HPLC analysis indicated a higher accumulation of 5-ALA-induced PpIX in the GBM samples compared with the AO sample. In total, 48 regions of interest were identified within the tumors from T2-WIs. In the GBM group, the relative T2 signal intensity value within the tumors following 5-ALA administration was significantly increased compared with the T2 signal intensity value prior to 5-ALA administration (1.537±0.021 and 1.577±0.023, respectively; P=0.0055). No significant differences were observed in the AO group. These results suggest that the 5-ALA-induced PpIX enhanced the T2 signal intensity in HGG. Therefore, 5-ALA may be a potentially useful MRI contrast reagent for HGG.

    DOI: 10.3892/ol.2016.5539

    PubMed

    researchmap

  • 5-aminolevulinic acid fluorescence in detection of peritoneal metastases

    Yutaka Yonemura, Emel Canbay, Haruaki Ishibashi, Eisei Nishino, Yoshio Endo, Shouzou Sako, Shun-ichiro Ogura

    Asian Pacific Journal of Cancer Prevention   Vol. 17   2017.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.7314/APJCP.2016.17.4.2271

    researchmap

  • Enhancement of 5-aminolevulinic acid-based fluorescence detection of side population-defined glioma stem cells by iron chelation. International journal

    Wenqian Wang, Kouichi Tabu, Yuichiro Hagiya, Yuta Sugiyama, Yasuhiro Kokubu, Yoshitaka Murota, Shun-Ichiro Ogura, Tetsuya Taga

    Scientific reports   7 ( No. 42070 )   42070 - 42070   2017.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Cancer stem cells (CSCs) are dominantly responsible for tumor progression and chemo/radio-resistance, resulting in tumor recurrence. 5-aminolevulinic acid (ALA) is metabolized to fluorescent protoporphyrin IX (PpIX) specifically in tumor cells, and therefore clinically used as a reagent for photodynamic diagnosis (PDD) and therapy (PDT) of cancers including gliomas. However, it remains to be clarified whether this method could be effective for CSC detection. Here, using flow cytometry-based analysis, we show that side population (SP)-defined C6 glioma CSCs (GSCs) displayed much less 5-ALA-derived PpIX fluorescence than non-GSCs. Among the C6 GSCs, cells with ultralow PpIX fluorescence exhibited dramatically higher tumorigenicity when transplanted into the immune-deficient mouse brain. We further demonstrated that the low PpIX accumulation in the C6 GSCs was enhanced by deferoxamine (DFO)-mediated iron chelation, not by reserpine-mediated inhibition of PpIX-effluxing ABCG2. Finally, we found that the expression level of the gene for heme oxygenase-1 (HO-1), a heme degradation enzyme, was high in C6 GSCs, which was further up-regulated when treated with 5-ALA. Our results provide important new insights into 5-ALA-based PDD of gliomas, particularly photodetection of SP-defined GSCs by iron chelation based on their ALA-PpIX-Heme metabolism.

    DOI: 10.1038/srep42070

    PubMed

    researchmap

  • Coating lanthanide nanoparticles with carbohydrate ligands elicits affinity for HeLa and RAW264.7 cells, enhancing their photodamaging effect. International journal

    Takashi Kanamori, Takashi Sawamura, Tatsumi Tanaka, Izumi Sotokawa, Ryota Mori, Kotaro Inada, Akihiro Ohkubo, Shun-Ichiro Ogura, Yasutoshi Murayama, Eigo Otsuji, Hideya Yuasa

    Bioorganic & medicinal chemistry   25 ( 2 )   743 - 749   2017.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Lanthanide nanoparticles (LNPs) conjugated with monosaccharides were synthesized as a photon energy-upconverting nanodevice with affinity to cancer cells. The conjugates were designed to selectively damage the cancer cells containing protoporphyrin IX, a photosensitizer endogenously synthesized from priorly administrated 5-aminolevlunic acid (ALA), by a highly tissue-penetrative near-infrared (NIR) irradiation. First of all, the affinities of monosaccharides toward cells (HeLa, RAW264.7, and MKN45) were assessed by a novel cell aggregation assay with trivalent monosaccharide-citric acid conjugates. As a result, HeLa exhibited high affinity for glucose, while RAW264.7 for glucose, galactose, mannose, and fucose. A similar cell-monosaccharide affinity was microscopically observed when the cells were mixed with monosaccharide-LNP conjugates and rinsed, in which the high affinity LNP probes luminesced on the cells. The high affinity monosaccharide-LNPs showed greater photodamaging effects than the unmodified LNP toward the corresponding cells, when the cells were pretreated with ALA and irradiated by NIR. This study demonstrates that carbohydrates can be used as selective ligands for cancer cells in a photodynamic therapy with LNP.

    DOI: 10.1016/j.bmc.2016.11.050

    PubMed

    researchmap

  • 5-aminolevulinic acid–induced protoporphyrin IX for high-grade gliomas: A prospective case study and clinical implications

    Junkoh Yamamoto, Shingo Kaneda, Tetsuya Yoneda, Shun-ichiro Ogura, Shohei Shimajiri, Tohru Tanaka, Yukinori Korogi, Shigeru Nishizawa

    Oncology Letters   Vol. 13   2016.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    researchmap

  • Dormant cancer cells accumulate high protoporphyrin IX levels and are sensitive to 5-aminolevulinic acid-based photodynamic therapy. International journal

    Taku Nakayama, Shimpei Otsuka, Tatsuya Kobayashi, Hodaka Okajima, Kentaro Matsumoto, Yuichiro Hagiya, Keiji Inoue, Taro Shuin, Motowo Nakajima, Tohru Tanaka, Shun-Ichiro Ogura

    Scientific reports   6 ( No. 36478 )   36478 - 36478   2016.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Photodynamic therapy (PDT) and diagnosis (PDD) using 5-aminolevulinic acid (ALA) to drive the production of an intracellular photosensitizer, protoporphyrin IX (PpIX), are in common clinical use. However, the tendency to accumulate PpIX is not well understood. Patients with cancer can develop recurrent metastatic disease with latency periods. This pause can be explained by cancer dormancy. Here we created uniformly sized PC-3 prostate cancer spheroids using a 3D culture plate (EZSPHERE). We demonstrated that cancer cells exhibited dormancy in a cell density-dependent manner not only in spheroids but also in 2D culture. Dormant cancer cells accumulated high PpIX levels and were sensitive to ALA-PDT. In dormant cancer cells, transporter expressions of PEPT1, ALA importer, and ABCB6, an intermediate porphyrin transporter, were upregulated and that of ABCG2, a PpIX exporter, was downregulated. PpIX accumulation and ALA-PDT cytotoxicity were enhanced by G0/G1-phase arrestors in non-dormant cancer cells. Our results demonstrate that ALA-PDT would be an effective approach for dormant cancer cells and can be enhanced by combining with a cell-growth inhibitor.

    DOI: 10.1038/srep36478

    PubMed

    researchmap

  • ランタニドナノ粒子を用いた光線力学治療技術の開発

    湯浅英哉, 小倉俊一郎

    化学工業   2016.8

     More details

    Language:Japanese   Publisher:化学工業社  

    researchmap

  • Photodynamic detection of canine mammary gland tumours after oral administration of 5-aminolevulinic acid

    Tomohiro Osaki, Inoru Yokoe, Shun-ichiro Ogura, Kiwamu Takahashi, Kiyotaka Murakami, Katsushi Inoue, Masahiro Ishizuka, Tohru Tanaka, Liming Li, Akihiko Sugiyama, Kazuo Azuma, Yusuke Murahata, Takeshi Tsuka, Norihiko Ito, Tomohiro Imagawa, Yoshiharu Okamoto

    Veterinary and Comparative Oncology   2016.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/vco.12213

    researchmap

  • 口腔がん組織由来の赤色蛍光:がん検知の可能性

    鬼木 玲奈, 寺原 航, 小島 涼, 長井 健一郎, 仲谷 将隆, 江南 慧, 増本 一真, 長田 哲次, 小倉俊一郎, 四ノ宮 成祥, 守本 祐司

    生体医工学   54 ( 26 )   2016

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)  

    DOI: 10.11239/jsmbe.54Annual.S89

    researchmap

  • Oxygen Availability for Porphyrin Biosynthesis Enzymes Determines the Production of Protoporphyrin IX (PpIX) during Hypoxia. International journal

    Shimpei Otsuka, Kentaro Matsumoto, Motowo Nakajima, Tohru Tanaka, Shun-Ichiro Ogura

    PloS one   10 ( 12 )   e0146026   2015.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    5-Aminolevulinic acid (ALA), a precursor of porphyrin, is specifically converted to the fluorescent substance protoporphyrin IX (PpIX) in tumors to be used as a prodrug for photodynamic therapy and diagnosis. Hypoxia, a common feature of solid tumors, decreases the efficacy of ALA-based photodynamic therapy and diagnosis. This decrease results from the excretion of porphyrin precursor coproporphyrinogen III (CPgenIII), an intermediate in the biosynthesis of PpIX. However, the mechanism of CPgenIII excretion during hypoxia remains unclear. In this study, we revealed the importance of mitochondrial respiration for the production of PpIX during hypoxia. Porphyrin concentrations were estimated in human gastric cancer cell lines by HPLC. Expression levels of porphyrin biosynthesis genes were measured by qRT-PCR and immunoblotting. Blockage of porphyrin biosynthesis was an oxygen-dependent phenomenon resulting from decreased PpIX production in mitochondria under hypoxic conditions. PpIX production was increased by the inhibition of mitochondrial respiration complexes, which indicates that the enzymes of porphyrin biosynthesis compete with respiration complexes for molecular oxygen. Our results indicate that targeting the respiration complexes is a rationale for enhancing the effect of ALA-mediated treatment and diagnosis.

    DOI: 10.1371/journal.pone.0146026

    PubMed

    researchmap

  • Silencing of ATPase Inhibitory Factor 1 Inhibits Cell Growth via Cell Cycle Arrest in Bladder Cancer. International journal

    Shihu Wei, Hideo Fukuhara, Chiaki Kawada, Atsushi Kurabayashi, Mutsuo Furihata, Shun-Ichiro Ogura, Keiji Inoue, Taro Shuin

    Pathobiology : journal of immunopathology, molecular and cellular biology   82 ( 5 )   224 - 32   2015.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    OBJECTIVE: The role of the ATPase inhibitory factor 1 (IF1) is inhibit the hydrolase activity of F1Fo-ATPase when oxidative phosphorylation is impaired. It has been demonstrated that IF1 is overexpressed in various carcinomas and mediates tumor cell activities, but the detailed mechanisms of IF1-mediated tumor progression and the link between IF1 and cell cycle progression remain unclear. Herein, we aimed to investigate the potential role of IF1 in cell cycle progression of human bladder cancer (BCa). METHODS: The expression of IF1 was analyzed by immunohistochemistry in tumor tissues. Western blot was used to detect protein expression in the cells. Cell proliferation was determined by MTT and colony formation assays. The cell cycle was analyzed using flow cytometry. RESULTS: We firstly showed IF1 was overexpressed in BCa. Silencing of IF1 by small interfering RNA led to a significant decrease in cell proliferation and migration in T24 and UM-UC-3 cells. Importantly, IF1 knockdown caused cell cycle arrest at G0/G1 stage and decreased the protein level of cyclin E/cyclin-dependent kinases (cdk) 2 and/or cyclin D/cdk4/cdk6. CONCLUSION: These results suggest the inhibitory effect of IF1 knockdown on BCa cell proliferation is via the suppression of cyclins and cdks related to G1/S transition and then induction of G0/G1 arrest, and firstly indicate IF1 mediates the tumor cell cycle. We concluded that IF1 may be a novel therapeutic target for BCa.

    DOI: 10.1159/000439027

    PubMed

    researchmap

  • The Effect of Coatings on the Affinity of Lanthanide Nanoparticles to MKN45 and HeLa Cancer Cells and Improvement in Photodynamic Therapy Efficiency. International journal

    Takashi Sawamura, Tatsumi Tanaka, Hiroyuki Ishige, Masayuki Iizuka, Yasutoshi Murayama, Eigo Otsuji, Akihiro Ohkubo, Shun-Ichiro Ogura, Hideya Yuasa

    International journal of molecular sciences   16 ( 9 )   22415 - 24   2015.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    An improvement in photodynamic therapy (PDT) efficiency against a human gastric cancer cell line (MKN45) with 5-aminolevulinic acid (ALA) and lanthanide nanoparticles (LNPs) is described. An endogenous photosensitizer, protoporphyrin IX, biosynthesized from ALA and selectively accumulated in cancer cells, is sensitizable by the visible lights emitted from up-conversion LNPs, which can be excited by a near-infrared light. Ten kinds of surface modifications were performed on LNPs, NaYF₄(Sc/Yb/Er) and NaYF₄(Yb/Tm), in an aim to distribute these irradiation light sources near cancer cells. Among these LNPs, only the amino-functionalized LNPs showed affinity to MKN45 and HeLa cancer cells. A PDT assay with MKN45 demonstrated that amino-modified NaYF₄(Sc/Yb/Er) gave rise to a dramatically enhanced PDT effect, reaching almost perfect lethality, whereas NaYF₄(Yb/Tm)-based systems caused little improvement in PDT efficiency. The improvement of PDT effect with the amino-modified NaYF₄(Sc/Yb/Er) is promising for a practical PDT against deep cancer cells that are reachable only by near-infrared lights.

    DOI: 10.3390/ijms160922415

    PubMed

    researchmap

  • The Effect of 5-Aminolevulinic Acid on Cytochrome P450-Mediated Prodrug Activation. International journal

    Mai Miura, Kensuke Ito, Maiko Hayashi, Motowo Nakajima, Tohru Tanaka, Shun-ichiro Ogura

    PloS one   10 ( 7 )   e0131793   2015.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Of late, numerous prodrugs are widely used for therapy. The hemeprotein cytochrome P450 (CYP) catalyzes the activation of prodrugs to form active metabolites. Therefore, the activation of CYP function might allow the use of lower doses of prodrugs and decrease toxicity. We hypothesized that the addition of 5-aminolevulinic acid (ALA), a precursor in the porphyrin biosynthetic pathway, enhances the synthesis of heme, leading to the up-regulation of CYP activity. To test this hypothesis, we treated a human gastric cancer cell line with ALA and determined the effect on CYP-dependent prodrug activation. For this purpose, we focused on the anticancer prodrug tegafur, which is converted to its active metabolite 5-fluorouracil (5-FU) mainly by CYP2A6. We show here that ALA increased CYP2A6-dependent tegafur activation, suggesting that ALA elevated CYP activity and potentiated the activation of the prodrug.

    DOI: 10.1371/journal.pone.0131793

    PubMed

    researchmap

  • Plasma protoporphyrin IX following administration of 5-aminolevulinic acid as a potential tumor marker. International journal

    Urara Ota, Hideo Fukuhara, Masahiro Ishizuka, Fuminori Abe, Chiaki Kawada, Kenji Tamura, Tohru Tanaka, Keiji Inoue, Shun-Ichiro Ogura, Taro Shuin

    Molecular and clinical oncology   3 ( 4 )   797 - 801   2015.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Exogenously administered 5-aminolevulinic acid (ALA) is metabolized to protoporphyrin IX (PpIX), which specifically accumulates in cancer cells and emits red fluorescence by blue light irradiation. These phenomena are applied for the intraoperative diagnosis of cancer. Based on the fact that accumulated PpIX in cancer cells is exported extracellularly via the ATP-binding cassette transporter G2, we hypothesized that the measurement of plasma PpIX concentrations could be applied as a tumor marker for cancer screening. In the present study, the use of plasma samples from bladder cancer patients were evaluated as a tumor marker. ALA, 1.0 g, was orally administered to bladder cancer patients and healthy adults. The plasma concentration of PpIX was measured using a high-performance liquid chromatography system. The plasma PpIX concentration following ALA administration was significantly higher in bladder cancer patients than that in the healthy adults, suggesting the effectiveness of plasma PpIX analysis following ALA administration for cancer screening. Additionally, 4 h after ALA administration, plasma PpIX showed high sensitivity (94.4%) and high specificity (80.0%).

    PubMed

    researchmap

  • Effects of plasma membrane ABCB6 on 5-aminolevulinic acid (ALA)-induced porphyrin accumulation in vitro: tumor cell response to hypoxia. International journal

    Kentaro Matsumoto, Yuichiro Hagiya, Yoshio Endo, Motowo Nakajima, Masahiro Ishizuka, Tohru Tanaka, Shun-ichiro Ogura

    Photodiagnosis and photodynamic therapy   12 ( 1 )   45 - 51   2015.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Currently, 5-aminolevulinic acid-based photodynamic diagnosis (ALA-PDD) is used to detect tumors during surgery and exploit tumor-specific accumulation of protoporphyrin IX (PpIX) after administration of ALA. In a recent study, we showed that the human ATP-binding cassette transporter ABCG2 plays a key role in the regulation of PpIX as a specific exporter. However, coproporphyrin III (CPIII) was also detected in urine after ALA administration in patients with tumor, indicating the presence of a CPIII transporter. METHODS: We used two lines of human gastric cancer cells to measure the ALA-induced porphyrin metabolism. Intracellular and extracellular porphyrin levels and expressions of transporter were determined. RESULTS: In the present study, we showed that although ABCG2 did not transport CPIII, plasma membrane ABCB6 did. Moreover, under conditions of hypoxia, the expression of ABCB6 in plasma membrane was upregulated, resulting in increased extracellular CPIII concentrations. CONCLUSION: These data indicate that the expression of ABCB6 in plasma membrane is important for porphyrin accumulation after ALA administration, including hypoxic conditions.

    DOI: 10.1016/j.pdpdt.2014.12.008

    PubMed

    researchmap

  • The effect of iron ion on the specificity of photodynamic therapy with 5-aminolevulinic acid. International journal

    Maiko Hayashi, Hideo Fukuhara, Keiji Inoue, Taro Shuin, Yuichiro Hagiya, Motowo Nakajima, Tohru Tanaka, Shun-ichiro Ogura

    PloS one   10 ( 3 )   e0122351   2015.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Recently, photodynamic therapy using 5-aminolevulinic acid (ALA-PDT) has been widely used in cancer therapy. ALA administration results in tumor-selective accumulation of the photosensitizer protoporphyrin IX (PpIX) via the heme biosynthetic pathway. Although ALA-PDT has selectivity for tumor cells, PpIX is accumulated into cultured normal cells to a small extent, causing side effects. The mechanism of tumor-selective PpIX accumulation is not well understood. The purpose of the present study was to identify the mechanism of tumor-selective PpIX accumulation after ALA administration. We focused on mitochondrial labile iron ion, which is the substrate for metabolism of PpIX to heme. We investigated differences in iron metabolism between tumor cells and normal cells and found that the amount of mitochondrial labile iron ion in cancer was lower than that in normal cells. This finding could be because of the lower expression of mitoferrins, which are the mitochondrial iron transporters. Accordingly, we added sodium ferrous citrate (SFC) with ALA as a source of iron. As a result, we observed the accumulation of PpIX only in tumor cells, and only these cells showed sensitivity to ALA-PDT. Taken together, these results suggest that the uptake abilities of iron ion into mitochondria play a key role in tumor-selective PpIX accumulation. Using SFC as a source of iron might thus increase the specificity of ALA-PDT effects.

    DOI: 10.1371/journal.pone.0122351

    PubMed

    researchmap

  • 5-Aminolevulinic acid enhances cell death under thermal stress in certain cancer cell lines. International journal

    Taku Chibazakura, Yui Toriyabe, Hiroshi Fujii, Kiwamu Takahashi, Mariko Kawakami, Haruna Kuwamura, Hazuki Haga, Shun-ichiro Ogura, Fuminori Abe, Motowo Nakajima, Hirofumi Yoshikawa, Tohru Tanaka

    Bioscience, biotechnology, and biochemistry   79 ( 3 )   422 - 31   2015.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    5-aminolevulinic acid (5-ALA) is contained in all organisms and a starting substrate for heme biosynthesis. Since administration of 5-ALA specifically leads cancer cells to accumulate protoporphyrin IX (PpIX), a potent photosensitizer, we tested if 5-ALA also serves as a thermosensitizer. 5-ALA enhanced heat-induced cell death of cancer cell lines such as HepG2, Caco-2, and Kato III, but not other cancer cell lines including U2-OS and normal cell lines including WI-38. Those 5-ALA-sensitive cancer cells, but neither U2-OS nor WI-38, accumulated intracellular PpIX and exhibited an increased reactive oxygen species (ROS) generation under thermal stress with 5-ALA treatment. In addition, blocking the PpIX-exporting transporter ABCG2 in U2-OS and WI-38 cells enhanced their cell death under thermal stress with 5-ALA. Finally, a ROS scavenger compromised the cell death enhancement by 5-ALA. These suggest that 5-ALA can sensitize certain cancer cells, but not normal cells, to thermal stress via accumulation of PpIX and increase of ROS generation.

    DOI: 10.1080/09168451.2014.975186

    PubMed

    researchmap

  • 5-aminolevulinic acid-induced protoporphyrin IX with multi-dose ionizing irradiation enhances host antitumor response and strongly inhibits tumor growth in experimental glioma in vivo. International journal

    Junkoh Yamamoto, Shun-Ichiro Ogura, Shohei Shimajiri, Yoshiteru Nakano, Daisuke Akiba, Takehiro Kitagawa, Kunihiro Ueta, Tohru Tanaka, Shigeru Nishizawa

    Molecular medicine reports   11 ( 3 )   1813 - 9   2015.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Ionizing irradiation is a well‑established therapeutic modality for malignant gliomas. Due to its high cellular uptake, 5‑aminolevulinic acid (ALA) is used for fluorescence‑guided resection of malignant gliomas. We have previously shown that 5‑ALA sensitizes glioma cells to irradiation in vitro. The aim of the present study was to assess whether 5‑ALA acts as a radiosensitizer in experimental glioma in vivo. Rats were subcutaneously injected with 9L gliosarcoma cells and administered 5‑ALA. The accumulation of 5‑ALA‑induced protoporphyrin IX was confirmed by high‑performance liquid chromatography (HPLC) analysis. Subcutaneous (s.c.) tumors were subsequently irradiated with 2 Gy/day for five consecutive days. In the experimental glioma model, high‑performance liquid chromatography analysis revealed a high level of accumulation of 5‑ALA‑induced protoporphyrin IX in s.c. tumors 3 h after 5‑ALA administration. Multi‑dose ionizing irradiation induced greater inhibition of tumor growth in rats that were administered 5‑ALA than in the non‑5‑ALA‑treated animals. Immunohistochemical analysis of the s.c. tumors revealed that numerous ionized calcium‑binding adapter molecule 1 (Iba1)‑positive macrophages gathered at the surface of and within the s.c. tumors following multi‑dose ionizing irradiation in combination with 5‑ALA administration. By contrast, the s.c. tumors in the control group scarcely showed aggregation of Iba1‑positive macrophages. These results suggested that multi‑dose ionizing irradiation with 5‑ALA induced not only a direct cytotoxic effect but also enhanced the host antitumor immune response and thus caused high inhibition of tumor growth in experimental glioma.

    DOI: 10.3892/mmr.2014.2991

    PubMed

    researchmap

  • 光増感剤を用いたがんの光線力学治療とがんの診断

    小倉俊一郎

    色材協会誌   88 ( 12 )   2015

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)  

    DOI: 10.4011/shikizai.88.416

    researchmap

  • Cytoreductive surgery under aminolevulinic acid-mediated photodynamic diagnosis plus hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from ovarian cancer and primary peritoneal carcinoma: results of a phase I trial. International journal

    Yang Liu, Yoshio Endo, Takuji Fujita, Haruaki Ishibashi, Toshihiro Nishioka, Emel Canbay, Yan Li, Shun-Ichiro Ogura, Yutaka Yonemura

    Annals of surgical oncology   21 ( 13 )   4256 - 62   2014.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: We conducted a phase I clinical trial to evaluate the sensitivity, specificity, and safety of cytoreductive surgery (CRS) under aminolevulinic acid-mediated photodynamic diagnosis (ALA-PDD) plus hyperthermic intraperitoneal chemotherapy (HIPEC) on 20 patients with peritoneal carcinomatosis (PC) from ovarian cancer and primary peritoneal carcinoma (PPC). PATIENTS AND METHODS: Patients took 5-aminolevulinic acid (5-ALA) at a dose of 20 mg/kg orally with 50 mL of water 2 h before surgery. During surgery, the abdominal cavity was observed under blue light (wavelength of 440 nm) before and after CRS plus HIPEC. Specimens were excised and submitted for pathological examination to evaluate the specificity of ALA-PDD. Postoperative course was closely monitored and detailed information was recorded. RESULTS: CRS under ALA-PDD plus HIPEC was performed 21 times in 20 patients with PC (16 ovarian cancer, 4 PPC) between June 2011 and October 2013. With the exception of 1 (5 %) patient, strong red fluorescence was detected in 19 patients with ovarian cancer, with a sensitivity of 95 %. All specimens from red fluorescent lesions were invaded by cancer cells, with a specificity of 100 %. No severe adverse events occurred during the perioperative period, with the exception of some abnormal laboratory results and mild complications. All patients were alive until the last follow-up. CONCLUSION: ALA-PDD provided a high sensitivity and specificity in detecting peritoneal metastasis in patients with PC from ovarian serous carcinoma and PPC. CRS under ALA-PDD plus HIPEC was a feasible and safe treatment option for patients with PC from ovarian cancer and PPC.

    DOI: 10.1245/s10434-014-3901-5

    PubMed

    researchmap

  • 生活週間病リスクに対する運動とALAサプリメントの予防効果に関する基礎的研究

    須田和裕, 柏瀬大志, 石渡貴之, 小倉俊一郎

    ソリューション科学に対する体系的研究2013   2014.3

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)  

    researchmap

  • The heme precursor 5-aminolevulinic acid disrupts the Warburg effect in tumor cells and induces caspase-dependent apoptosis. International journal

    Yuta Sugiyama, Yuichiro Hagiya, Motowo Nakajima, Masahiro Ishizuka, Tohru Tanaka, Shun-Ichiro Ogura

    Oncology reports   31 ( 3 )   1282 - 6   2014.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Our previous study demonstrated that 5-aminolevulinic acid (ALA) administered to mice stimulates oxidative phosphorylation by upregulation of the mitochondrial respiratory chain complex IV enzyme cytochrome c oxidase (COX). The present study investigated whether ALA disrupts the Warburg effect, which represents a shift in ATP generation from oxidative phosphorylation to glycolysis, protecting tumor cells against oxidative stress-mediated apoptosis. The human lung carcinoma cell line A549 exposed to ALA exhibited enhanced oxidative phosphorylation, which was indicated by an increase in COX protein expression and oxygen consumption. Furthermore, ALA suppressed glycolysis-mediated acidosis. This normalization of the ATP metabolic pathways significantly increased the generation of superoxide anion radical (O2•-) and the functional expression of active caspase-3, leading to caspase-dependent apoptosis. These data demonstrate that ALA inhibits the Warburg effect and induces cancer cell death. Use of this endogenous compound might constitute a novel approach to cancer therapy.

    DOI: 10.3892/or.2013.2945

    PubMed

    researchmap

  • Photodynamic detection and management of intraperitoneal spreading of primary peritoneal papillary serous carcinoma in a man: report of a case.

    Emel Canbay, Haruaki Ishibashi, Shouzou Sako, Toshiyuki Kitai, Eisei Nishino, Masamitsu Hirano, Akiyoshi Mizumoto, Yoshio Endo, Shun-Ichiro Ogura, Yutaka Yonemura

    Surgery today   44 ( 2 )   373 - 7   2014.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    As a peritoneal surface malignancy, primary peritoneal papillary serous carcinoma (PPPSC) almost always occurs in women. Our search of the literature found only two previous case reports of men with PPPSC, both with very short survival. We report the case of a 63-year-old man with PPPSC, treated effectively with cytoreductive surgery and docetaxel-based hyperthermic intraperitoneal chemotherapy following six cycles of docetaxel-based laparoscopic neoadjuvant intraperitoneal and cisplatin-based systemic chemotherapy. Furthermore, we detected intraoperative intraperitoneal spreading of the tumor after the oral administration of 5-amino levulinic acid (5-ALA). The patient remains in good health without ascites 18 months after his diagnosis. Thus, primary peritoneal papillary serous carcinoma should be managed by intraperitoneal chemotherapy combined with peritonectomy procedures. Moreover, the intraoperative detection of the intraperitoneal spreading of the tumor after administering oral 5-ALA shows that this is an exciting and promising diagnostic technique, which needs to be confirmed by further studies.

    DOI: 10.1007/s00595-013-0500-1

    PubMed

    researchmap

  • The effects of the heme precursor 5-aminolevulinic acid (ALA) on REV-ERBα activation. International journal

    Kohei Yamashita, Yuichiro Hagiya, Motowo Nakajima, Masahiro Ishizuka, Tohru Tanaka, Shun-Ichiro Ogura

    FEBS open bio   4   347 - 52   2014

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The nuclear receptor, REV-ERBα, has a key role in circadian rhythms and requires heme as its ligand. The present study determined whether the heme precursor, 5-aminolevulinic acid (ALA), affects REV-ERBα and its target genes. When exposed to ALA, the human lung diploid cell line, WI-38, exhibited activation of REV-ERBα and repression of the transcription of REV-ERBα target genes, including BMAL1, an essential component of the circadian oscillator. Moreover, co-incubation of sodium ferrous citrate (SFC) and ALA also activated REV-ERBα and repressed the transcription of REV-ERBα target genes. These results indicate that ALA regulates human circadian rhythms via REV-ERBα.

    DOI: 10.1016/j.fob.2014.03.010

    PubMed

    researchmap

  • Access to a novel near-infrared photodynamic therapy through the combined use of 5-aminolevulinic acid and lanthanide nanoparticles. International journal

    Atsushi Shimoyama, Hiroya Watase, Yu Liu, Shun-ichiro Ogura, Yuichiro Hagiya, Kiwamu Takahashi, Katsushi Inoue, Tohru Tanaka, Yasutoshi Murayama, Eigo Otsuji, Akihiro Ohkubo, Hideya Yuasa

    Photodiagnosis and photodynamic therapy   10 ( 4 )   607 - 14   2013.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: There have been considerable efforts to develop photodynamic therapy (PDT) for cancer, in which photoirradiation of a sensitizer delivered near cancer cells results in the conversion of oxygen into active species, causing cell destruction. Aiming at the best cancer selectivity, one PDT method employed protoporphyrin IX (PPIX), which selectively accumulated in cancer cells after oral administration of 5-aminolevulinic acid (ALA). The drawback, however, is that blue incident lights are required to excite PPIX, resulting in low tissue penetrability, and therefore limiting its application to surface cancers. METHODS: To overcome the low penetrability of the incident light, we employed a light energy upconverter, lanthanide nanoparticle (LNP), which, upon irradiation with highly penetrative near-infrared (NIR) radiation, emits visible light within the Q-band region of PPIX absorbance allowing its sensitization. To discover the optimum conditions for the LNP-assisted PDT, the cytotoxicity and PPIX-sensitizability of LNPs were first studied. Then, the LNP-assisted PDT was validated using the MKN45 cell line: cells were pretreated with ALA and LNP, irradiated with a 975-nm diode laser, and subjected to MTT assay to measure cell viability. RESULTS: The singlet oxygen generation on NIR-irradiation of the PPIX-LNP mixture was proved, indicating that the emission from LNP could excite the PPIX sensitizer. An intermittent NIR-irradiation for 32 min of MKN45, pretreated with LNP (1mg/mL) and ALA (2mM), caused 87% cell destruction. CONCLUSIONS: The potential applicability of the NIR-irradiation PDT with ALA- and LNP-pretreated cancer cells was demonstrated.

    DOI: 10.1016/j.pdpdt.2013.07.005

    PubMed

    researchmap

  • Porphyrins as urinary biomarkers for bladder cancer after 5-aminolevulinic acid (ALA) administration: the potential of photodynamic screening for tumors. International journal

    Keiji Inoue, Urara Ota, Masahiro Ishizuka, Chiaki Kawada, Hideo Fukuhara, Taro Shuin, Ichiro Okura, Tohru Tanaka, Shun-ichiro Ogura

    Photodiagnosis and photodynamic therapy   10 ( 4 )   484 - 9   2013.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Tumor biomarkers are commonly used for cancer screening and as indicators of treatment effects. We recently reported that urine porphyrin levels from tumor-bearing mice were elevated compared with those from normal mice after administration of 5-aminolevulinic acid (ALA). In the present study, we evaluated the use of urine samples from bladder cancer patients as tumor biomarkers. METHODS: ALA, 1.0 g, was orally administered to 66 bladder cancer patients and 20 healthy adults. The urine concentrations of uroporphyrin I (UPI), uroporphyrin III (UPIII), coproporphyrin I (CPI), coproporphyrin III (CPIII), and total porphyrins were measured using High Performance Liquid Chromatography (HPLC) system. RESULTS: Almost all of the urinary porphyrin concentrations from the patients with bladder cancer were higher than those from healthy adults. Moreover, 8h after ALA administration, urinary UPI and CPI showed high sensitivity (100 for UPI and CPI) and specificity (96.4 for UPI and 91.4 for CPI). CONCLUSION: These results indicate that the presence of urinary porphyrins after administration of ALA may function as tumor biomarkers. This method represents a possible new tumor screening method called photodynamic screening (PDS) using ALA-induced porphyrins.

    DOI: 10.1016/j.pdpdt.2013.05.002

    PubMed

    researchmap

  • Synergy of ferrous ion on 5-aminolevulinic acid-mediated growth inhibition of Plasmodium falciparum. International journal

    Keisuke Komatsuya, Masayuki Hata, Emmanuel O Balogun, Kenji Hikosaka, Shigeo Suzuki, Kiwamu Takahashi, Tohru Tanaka, Motowo Nakajima, Shun-Ichiro Ogura, Shigeharu Sato, Kiyoshi Kita

    Journal of biochemistry   154 ( 6 )   501 - 4   2013.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Haem biosynthesis appeared to be a target of malaria therapy because 5-aminolevulinic acid (ALA), a haem biosynthesis starting material, with light exposure or a high amount of ALA alone reduced Plasmodium falciparum growth to undetectable level. However, the administration of a high dose of ALA is unrealistic for clinical therapy. We found that Fe(2+) enhanced P. falciparum-killing potency of ALA and significantly inhibited the parasite growth. The intermediates of haem biosynthesis localized to the parasite organelles, and coproporphyrin III was the most accumulated intermediate. These novel findings may lead to development of a new anti-malarial drug using ALA and Fe(2+).

    DOI: 10.1093/jb/mvt096

    PubMed

    researchmap

  • Expression levels of PEPT1 and ABCG2 play key roles in 5-aminolevulinic acid (ALA)-induced tumor-specific protoporphyrin IX (PpIX) accumulation in bladder cancer. International journal

    Yuichiro Hagiya, Hideo Fukuhara, Kentaro Matsumoto, Yoshio Endo, Motowo Nakajima, Tohru Tanaka, Ichiro Okura, Atsushi Kurabayashi, Mutsuo Furihata, Keiji Inoue, Taro Shuin, Shun-Ichiro Ogura

    Photodiagnosis and photodynamic therapy   10 ( 3 )   288 - 95   2013.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: A detection method widely used of late in cancer surgery is 5-aminolevulinic acid-based photodynamic diagnosis (ALA-PDD), which relies on the tumor-specific accumulation of photosensitizing protoporphyrin IX (PpIX) after the administration of ALA. In this regard, we recently reported that peptide transporter PEPT1 and human ATP-binding cassette transporter ABCG2 are key players in regulating intracellular PpIX levels. In the present study, we re-evaluated in vivo the expression of genes involved in the porphyrin biosynthesis pathway. METHODS: Using quantitative real-time (qRT)-PCR, we measured the mRNA levels in a clinical specimen of bladder cancer from a patient who had been subjected to ALA-PDD. RESULTS: We confirmed that PEPT1 and ABCG2 are major contributors to the regulation of tumor-specific PpIX accumulation. qRT-PCR analysis revealed a predominantly high level of PEPT1 mRNA and a very low level of ABCG2 mRNA in the bladder cancer, corresponding to the roles of these genes in vitro. These findings were further confirmed by immunohistochemical studies with PEPT1- and ABCG2-specific antibodies. CONCLUSION: The induction of PEPT1 gene and the suppression of ABCG2 gene expression are among the key molecular mechanisms underlying tumor-specific PpIX accumulation after the administration of ALA in bladder cancer.

    DOI: 10.1016/j.pdpdt.2013.02.001

    PubMed

    researchmap

  • Sugar-attached upconversion lanthanide nanoparticles: a novel tool for high-throughput lectin assay. International journal

    Yu Liu, Takuya Kobayashi, Masayuki Iizuka, Tatsumi Tanaka, Izumi Sotokawa, Atsushi Shimoyama, Yasutoshi Murayama, Eigo Otsuji, Shun-ichiro Ogura, Hideya Yuasa

    Bioorganic & medicinal chemistry   21 ( 11 )   2832 - 42   2013.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    To create a novel high-throughput lectin assay (HTPLA) method based on the emission of a luminophore by highly penetrable near-infrared excitation, sugar-attached upconversion lanthanide nanoparticles (LNPs) were synthesized as a tool to highlight the aggregates caused by the sugar-mediated specific bridging between LNP and lectin. The emissions from a mannose-coated LNP in the aggregates with a mannose-binding lectin were much stronger than those from the non-aggregated samples, being sensitive enough for HTPLA. A galactose-coated LNP was also applicable to a macrophage aggregation assay for the sugar specificity of its surface lectin.

    DOI: 10.1016/j.bmc.2013.04.008

    PubMed

    researchmap

  • Improvement of aminolevulinic acid (ALA)-mediated photodynamic diagnosis using n-propyl gallate. International journal

    Tomohisa Hirano, Yuichiro Hagiya, Hideo Fukuhara, Keiji Inoue, Taro Shuin, Kentaro Matsumoto, Katsushi Inoue, Tohru Tanaka, Ichiro Okura, Shun-Ichiro Ogura

    Photodiagnosis and photodynamic therapy   10 ( 1 )   28 - 32   2013.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Photodynamic diagnosis (PDD) using aminolevulinic acid (ALA) is widely used in clinical fields. In PDD, protoporphyrin IX (PpIX) is generated from ALA in tumors, allowing the detection of the tumors by PpIX fluorescence. However, it is well known that PpIX is bleached by light irradiation (photobleaching) resulting in reduced PDD efficiency. In this study, n-propyl gallate (NPG) was investigated as an enhancer of PDD efficiency. METHODS: Tumor cells were incubated with NPG after treatment with ALA, and reactive oxygen species and PpIX fluorescence were measured. RESULTS: The antioxidant NPG suppressed the production of reactive oxygen species from light-irradiated porphyrins and ameliorated photobleaching of PpIX generated from ALA in vitro and in vivo. CONCLUSION: Incubation with NPG decreased the production of reactive oxygen species from PpIX and suppressed PpIX photobleaching. These results indicate that the antioxidant NPG may significantly improve PDD efficiency.

    DOI: 10.1016/j.pdpdt.2012.06.002

    PubMed

    researchmap

  • Investigation of proNT/NMN secretion from small cell lung carcinoma cells using a mouse xenograft model. International journal

    Kanako Wakabayashi-Nakao, Koji Maruyama, Hidee Ishii, Koji Muramatsu, Keiichi Hatakeyama, Keiichi Ohshima, Shun-Ichiro Ogura, Takashi Nakajima, Ken Yamaguchi, Tohru Mochizuki

    Oncology reports   28 ( 4 )   1181 - 6   2012.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Proneurotensin/neuromedin N (proNT/NMN), the precursor of neurotensin (NT) and neuromedin N (NMN), is produced by cancer tissues derived from the pancreas and colon. NT stimulates tumor growth and proliferation through its receptors; however, little is known about the precursor molecule in cancer tissues. We previously demonstrated that proNT/NMN is secreted from small cell lung carcinoma (SCLC) cell lines in serum-free conditioned medium, but not from non-small cell lung carcinoma (NSCLC) cell lines. It was suggested that this precursor may serve as a tumor marker for SCLC. In this study, we established in vivo xenograft models to evaluate the possibility of proNT/NMN as a specific tumor marker. SBC3 cells, derived from human SCLC, were inoculated into mice, and the proNT/NMN levels in plasma and tumor tissues were detected using specific antibodies. In contrast to control mouse plasma, the proNT/NMN levels in tumor-bearing mice increased as the tumors grew, and the elevated plasma proNT/NMN levels were decreased by tumor resection. Moreover, proNT/NMN was expressed in SBC3 tumors, suggesting that proNT/NMN was secreted into blood from the tumor, and this secretion may be specific to SCLC.

    DOI: 10.3892/or.2012.1926

    PubMed

    researchmap

  • Pivotal roles of peptide transporter PEPT1 and ATP-binding cassette (ABC) transporter ABCG2 in 5-aminolevulinic acid (ALA)-based photocytotoxicity of gastric cancer cells in vitro. International journal

    Yuichiro Hagiya, Yoshio Endo, Yutaka Yonemura, Kiwamu Takahashi, Masahiro Ishizuka, Fuminori Abe, Tohru Tanaka, Ichiro Okura, Motowo Nakajima, Toshihisa Ishikawa, Shun-Ichiro Ogura

    Photodiagnosis and photodynamic therapy   9 ( 3 )   204 - 14   2012.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Recently, 5-aminolevulinic acid-based photodynamic therapy (ALA-PDT) is being widely used in cancer therapy owing to the tumor-specific accumulation of photosensitizing protoporphyrin IX (PpIX) after the administration of ALA. In the present study, by focusing on genes involved in the porphyrin biosynthesis pathway, we aimed to explore biomarkers that are predictive for the efficacy of ALA-PDT. METHODS: We used five lines of human gastric cancer cells to measure the ALA-based photocytotoxicity. ALA-induced production of PpIX in cancer cells was quantified by fluorescence spectrophotometry. To examine the potential involvement of PEPT1 and ABCG2 in the ALA-PDT sensitivity, stable cell lines overexpressing PEPT1 were established and ABCG2-specific siRNA used. RESULTS: We observed that three cell lines were photosensitive, whereas the other two cell lines were resistant to ALA-based photocytotoxicity. The ALA-based photocytotoxicity was found to be well correlated with intracellular PpIX levels, which suggests that certain enzymes and/or transporters involved in ALA-induced PpIX production are critical determinants. We found that high expression of the peptide transporter PEPT1 (ALA influx transporter) and low expression of the ATP-binding cassette transporter ABCG2 (porphyrin efflux transporter) determined ALA-induced PpIX production and cellular photosensitivity in vitro. CONCLUSION: PEPT1 and ABCG2 are key players in regulating intracellular PpIX levels and determining the efficacy of ALA-based photocytotoxicity against gastric cancer cells in vitro. Evaluation of the expression levels of PEPT1 and ABCG2 genes could be useful to predict the efficacy of ALA-PDT. Primers specific to those target genes are practical and useful biomarkers for predicting the photo-sensitivity to ALA-PDT.

    DOI: 10.1016/j.pdpdt.2011.12.004

    PubMed

    researchmap

  • Syntheses, characterization, and antitumor activities of platinum(II) and palladium(II) complexes with sugar-conjugated triazole ligands. International journal

    Shigenobu Yano, Hiromi Ohi, Mizue Ashizaki, Makoto Obata, Yuji Mikata, Rika Tanaka, Takanori Nishioka, Isamu Kinoshita, Yuko Sugai, Ichiro Okura, Shun-ichiro Ogura, Justyna A Czaplewska, Michael Gottschaldt, Ulrich S Schubert, Takuzo Funabiki, Keiko Morimoto, Misaki Nakai

    Chemistry & biodiversity   9 ( 9 )   1903 - 15   2012.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Four platinum(II) and palladium(II) complexes with sugar-conjugated bipyridine-type triazole ligands, [Pt(II)Cl(2)(AcGlc-pyta)] (3), [Pd(II)Cl(2)(AcGlc-pyta)] (4), [Pt(II)Cl(2)(Glc-pyta)] (5), and [Pd(II)Cl(2)(Glc-pyta)] (6), were prepared and characterized by mass spectrometry, elemental analysis, (1)H- and (13)C-NMR, IR as well as UV/VIS spectroscopy, where AcGlc-pyta and Glc-pyta denote 2-[4-(pyridin-2-yl)-1H-1,2,3-triazol-1-yl]ethyl 2,3,4,6-tetra-O-acetyl-β-D-glucopyranoside (1) and 2-[4-(pyridin-2-yl)-1H-1,2,3-triazol-1-yl]ethyl β-D-glucopyranoside (2), respectively. The solid-state structure of complex 6 was determined by single-crystal X-ray-diffraction analysis. These complexes exhibited in vitro cytotoxicity against human cervix tumor cells (HeLa) though weaker than that of cisplatin.

    DOI: 10.1002/cbdv.201100426

    PubMed

    researchmap

  • 分子生物学の最近の話題 : がんの化学治療

    小倉俊一郎

    電子情報通信学会誌 = The journal of the Institute of Electronics, Information and Communication Engineers   95 ( 8 )   2012.8

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)  

    researchmap

  • Radiosensitizing effect of 5-aminolevulinic acid-induced protoporphyrin IX in glioma cells in vitro. International journal

    Junkoh Yamamoto, Shun-Ichiro Ogura, Tohru Tanaka, Takehiro Kitagawa, Yoshiteru Nakano, Takeshi Saito, Mayu Takahashi, Daisuke Akiba, Shigeru Nishizawa

    Oncology reports   27 ( 6 )   1748 - 52   2012.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    5-Aminolevulinic acid (ALA) is a prodrug used in photodynamic therapy and fluorescence-guided resection of malignant gliomas due to its high cellular uptake in tumours. Porphyrin compounds act not only as photosensitizers but also as radiosensitizers. In the present study, the possible use of 5-ALA as a radiosensitizer for malignant gliomas was examined in vitro. Rat glioma cell lines (9L, C6) were pre-treated with 5-ALA and exposed to ionizing irradiation. The radiosensitizing effect of 5-ALA was evaluated by colony-forming assay. Intracellular reactive oxygen species (ROS) produced by 5-ALA and irradiation were evaluated by confocal laser scanning microscopy. Pre-treatment with 5-ALA enhanced the radiosensitivity of 9L cells to single-dose ionizing irradiation compared with controls (D0 value, 4.35 ± 0.20 and 4.84 ± 0.23 Gy, respectively, P ≤ 0.05). Exposure to multi-dose ionizing irradiation revealed high radiosensitivity in both 9L and C6 cells pre-treated with 5-ALA compared to controls. Production of intracellular ROS increased in 9L cells pre-treated with 5-ALA after ionizing irradiation compared to control cells. Thus, 5-ALA functions as a specific radiosensitizer for malignant gliomas. Intracellular 5-ALA-induced PpIX plays an important role in the production of ROS and the radiosensitizing effect under ionizing irradiation conditions.

    DOI: 10.3892/or.2012.1699

    PubMed

    researchmap

  • Novel protein extraction approach using micro-sized chamber for evaluation of proteins eluted from formalin-fixed paraffin-embedded tissue sections. International journal

    Keiichi Hatakeyama, Kanako Wakabayashi-Nakao, Yutaka Aoki, Shun-Ichiro Ogura, Ken Yamaguchi, Takashi Nakajima, Taka-Aki Sato, Tohru Mochizuki, Isamu Hayashi

    Proteome science   10   19 - 19   2012.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    We describe a novel antigen-retrieval method using a micro-sized chamber for mass spectrometry (MS) analysis to identify proteins that are preferentially eluted from formalin-fixed paraffin-embedded (FFPE) samples. This approach revealed that heat-induced antigen retrieval (HIAR) from an FFPE sample fixed on a glass slide not only improves protein identification, but also facilitates preferential elution of protein subsets corresponding to the properties of antigen-retrieval buffers. Our approach may contribute to an understanding of the mechanism of HIAR.

    DOI: 10.1186/1477-5956-10-19

    PubMed

    researchmap

  • Improvement of tumor localization of photosensitizers for photodynamic therapy and its application for tumor diagnosis. International journal

    Shun-Ichiro Ogura, Yuichiro Hagiya, Kenji Tabata, Toshiaki Kamachi, Ichiro Okura

    Current topics in medicinal chemistry   12 ( 3 )   176 - 84   2012

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Photodynamic therapy (PDT) and photodynamic diagnosis of cancer are widely used in clinical fields. These are performed using photosensitizers. Many metalloporphyrin-related compounds have been developed as photosensitizers for use in PDT, and these tumor localization ability have been improved in recent research. Moreover, the precursor of porphyrin 5-aminolevulinic acid is used in fluorescence diagnosis using its tumor localization ability. In this review, these applications of photosensitizers in cancer therapy and diagnosis are summarized.

    PubMed

    researchmap

  • Porphyrins in urine after administration of 5-aminolevulinic acid as a potential tumor marker. International journal

    Masahiro Ishizuka, Yuichiro Hagiya, Yasuhiro Mizokami, Kanako Honda, Kenji Tabata, Toshiaki Kamachi, Kiwamu Takahashi, Fuminori Abe, Tohru Tanaka, Motowo Nakajima, Shun-ichiro Ogura, Ichiro Okura

    Photodiagnosis and photodynamic therapy   8 ( 4 )   328 - 31   2011.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Tumor markers are commonly used for cancer screening and as indicators of therapeutic effects. Certain types of tumor have been known to produce a variety of porphyrins after 5-aminolevulinic acid (ALA) administration. In this study, porphyrins in tumor-bearing mouse urine were analyzed after oral administration of ALA in order to identify new tumor markers excreted in the urine. METHODS: Porphyrin concentrations in the urine of tumor-bearing mice were measured after administration of 1.0mg of ALA (approximately 50mgkg(-1)). RESULTS: Porphyrin concentrations in the urine of tumor-bearing mice increased after administration of ALA. HPLC analysis of the urine revealed the existence of uroporphyrin (UP) and coproporphyrin (CP) in the urine of ALA-treated tumor-bearing mice. Furthermore, at 3h after ALA administration, UP concentrations in the urine of tumor-bearing mice significantly increased compared to those in the urine of normal mice. CONCLUSION: These results suggest that UP as a precursor of heme detected in the urine of tumor-bearing mice after ALA administration is a potential marker of tumor development.

    DOI: 10.1016/j.pdpdt.2011.04.004

    PubMed

    researchmap

  • Enhanced expression of coproporphyrinogen oxidase in malignant brain tumors: CPOX expression and 5-ALA-induced fluorescence. International journal

    Kenkichi Takahashi, Naokado Ikeda, Naosuke Nonoguchi, Yoshinaga Kajimoto, Shin-Ichi Miyatake, Yuichiro Hagiya, Shun-Ichiro Ogura, Hiroshi Nakagawa, Toshihisa Ishikawa, Toshihiko Kuroiwa

    Neuro-oncology   13 ( 11 )   1234 - 43   2011.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    In photodynamic diagnosis, 5-aminolevulinic acid (5-ALA) is widely used for the fluorescence-guided resection of malignant brain tumors, where 5-ALA is converted to protoporphyrin IX, which exhibits strong fluorescence. Little is known, however, about the detailed molecular mechanisms underlying 5-ALA-induced fluorescence. To resolve this issue, we analyzed transcriptome profiles for the genes encoding enzymes, transporters, and a transcription factor involved in the porphyrin-biosynthesis pathway. By quantitative real-time (qRT)-PCR, we measured the mRNA levels of those genes in a total of 20 tumor samples that had been surgically resected from brain tumor patients at the Department of Neurosurgery of Osaka Medical College from 2008 to 2009. We selected 10 tumor samples with no 5-ALA-induced fluorescence, among which 2 were glioblastomas and 8 were metastatic brain tumors. Another 10 tumor samples were selected with strong fluorescence, among which 7 were glioblastomas and 3 were metastatic brain tumors. The qRT-PCR analysis study of these latter 10 samples revealed predominantly high levels of the mRNA of the coproporphyrinogen oxidase (CPOX) gene. The high mRNA level of CPOX expression was significantly well correlated with the phenotype of strong 5-ALA-induced fluorescence (P = .0003). These findings were further confirmed by immunohistochemical studies with a CPOX-specific antibody. It is concluded that induction of CPOX gene expression is one of the key molecular mechanisms underlying the 5-ALA-induced fluorescence of malignant brain tumors. The induction mechanism for the CPOX gene in brain tumors remains to be elucidated.

    DOI: 10.1093/neuonc/nor116

    PubMed

    researchmap

  • Transporter-Mediated Drug Interaction Strategy for 5-Aminolevulinic Acid (ALA)-Based Photodynamic Diagnosis of Malignant Brain Tumor: Molecular Design of ABCG2 Inhibitors. International journal

    Toshihisa Ishikawa, Kenkichi Takahashi, Naokado Ikeda, Yoshinaga Kajimoto, Yuichiro Hagiya, Shun-Ichiro Ogura, Shin-Ichi Miyatake, Toshihiko Kuroiwa

    Pharmaceutics   3 ( 3 )   615 - 35   2011.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Photodynamic diagnosis (PDD) is a practical tool currently used in surgical operation of aggressive brain tumors, such as glioblastoma. PDD is achieved by a photon-induced physicochemical reaction which is induced by excitation of protoporphyrin IX (PpIX) exposed to light. Fluorescence-guided gross-total resection has recently been developed in PDD, where 5-aminolevulinic acid (ALA) or its ester is administered as the precursor of PpIX. ALA induces the accumulation of PpIX, a natural photo-sensitizer, in cancer cells. Recent studies provide evidence that adenosine triphosphate (ATP)-binding cassette (ABC) transporter ABCG2 plays a pivotal role in regulating the cellular accumulation of porphyrins in cancer cells and thereby affects the efficacy of PDD. Protein kinase inhibitors are suggested to potentially enhance the PDD efficacy by blocking ABCG2-mediated porphyrin efflux from cancer cells. It is of great interest to develop potent ABCG2-inhibitors that can be applied to PDD for brain tumor therapy. This review article addresses a pivotal role of human ABC transporter ABCG2 in PDD as well as a new approach of quantitative structure-activity relationship (QSAR) analysis to design potent ABCG2-inhibitors.

    DOI: 10.3390/pharmaceutics3030615

    PubMed

    researchmap

  • Identification of a novel protein isoform derived from cancer-related splicing variants using combined analysis of transcriptome and proteome. International journal

    Keiichi Hatakeyama, Keiichi Ohshima, Yorikane Fukuda, Shun-ichiro Ogura, Masanori Terashima, Ken Yamaguchi, Tohru Mochizuki

    Proteomics   11 ( 11 )   2275 - 82   2011.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Splicing variation enhances proteome diversity and modulates cancer-associated proteins. Thus, the identification of alternative splice forms is significant for discovery of new cancer-related biomarkers. However, relatively few screening approaches of alternative splicing via proteomics have been reported. In the present study, we describe a combined analysis with proteome and transcriptome to simultaneously identify cancer-related splicing variants and splicing variant-derived protein fragments that are differentially expressed in a highly metastatic gastric cancer cell line MKN45P versus its parental cell line MKN45. We found three potential alternative-spliced genes using MS-based shotgun method and two different microarray platforms. Among them, aldolase C, fructose-bisphosphate (ALDOC) was predicted to have novel alternative splice forms. We successfully identified and validated novel splice forms of ALDOC gene by RT-PCR and DNA sequencing analyses, the expression level of which were higher in MKN45P than in MKN45. Furthermore, the protein fragment derived from the validated splicing variant was identified using custom-built data set including sequences of ALDOC variants in MS/MS analysis. Our combined analysis will be a promising technique for screening of cancer-related splicing variants and their protein isoforms.

    DOI: 10.1002/pmic.201100016

    PubMed

    researchmap

  • 5-アミノレブリン酸を用いたPDD, PDTの現状と将来

    田中 徹, 石塚 昌宏, 小倉俊一郎, 井上 克司

    Japanese journal of Endourology   24 ( 1 )   2011.5

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)  

    DOI: 10.11302/jsejje.24.29

    researchmap

  • Selection of DNA aptamers recognizing small cell lung cancer using living cell-SELEX. International journal

    Takao Kunii, Shun-ichiro Ogura, Masayasu Mie, Eiry Kobatake

    The Analyst   136 ( 7 )   1310 - 2   2011.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    We applied Systematic Evolution of Ligands by EXponential enrichment using Small Cell Lung Cancer (SCLC) cells. A DNA aptamer was identified and evaluated by fluorescent confocal microscopy and flow cytometry. Our results showed that the DNA aptamer binds to molecules that exist predominantly on target SCLC cell surfaces compared with other types of SCLC cells.

    DOI: 10.1039/c0an00962h

    PubMed

    researchmap

  • The effect of 5-aminolevulinic acid on cytochrome c oxidase activity in mouse liver. International journal

    Shun-Ichiro Ogura, Kouji Maruyama, Yuichiro Hagiya, Yuta Sugiyama, Kyoko Tsuchiya, Kiwamu Takahashi, Fuminori Abe, Kenji Tabata, Ichiro Okura, Motowo Nakajima, Tohru Tanaka

    BMC research notes   4   66 - 66   2011.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: 5-Aminolevulinic acid (ALA) is a precursor of heme that is fundamentally important in aerobic energy metabolism. Among the enzymes involved in aerobic energy metabolism, cytochrome c oxidase (COX) is crucial. In this study, the effect of ALA on cytochrome c oxidase activity was measured. FINDINGS: c57BL/6N species of mice were administered ALA orally for 15 weeks. After ALA administration, mice were sacrificed and livers were obtained. COX activity in mitochondria from ALA-administered mouse livers was 1.5-fold higher than that in mitochondria from PBS-administered mouse livers (P < 0.05). Furthermore, ATP levels in ALA-administered mouse livers were much higher than those in PBS-administered mouse livers. These data suggest that oral administration of ALA promotes aerobic energy metabolism, especially COX activity. CONCLUSIONS: This is the first report of a drug that functions in aerobic energy metabolism directly. Since COX activity is decreased in various diseases and aging, the pharmacological effects of ALA will be expanding.

    DOI: 10.1186/1756-0500-4-66

    PubMed

    researchmap

  • Novel development of 5-aminolevurinic acid (ALA) in cancer diagnoses and therapy. International journal

    Masahiro Ishizuka, Fuminori Abe, Yuki Sano, Kiwamu Takahashi, Katsushi Inoue, Motowo Nakajima, Takeo Kohda, Naoki Komatsu, Shun-ichiro Ogura, Tohru Tanaka

    International immunopharmacology   11 ( 3 )   358 - 65   2011.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Early detection and intervention are needed for optimal outcomes in cancer therapy. Improvements in diagnostic technology, including endoscopy, photodynamic diagnosis (PDD), and photodynamic therapy (PDT), have allowed substantial progress in the treatment of cancer. 5-Aminolevulinic acid (ALA) is a natural, delta amino acid biosynthesized by animal and plant mitochondria. ALA is a precursor of porphyrin, heme, and bile pigments, and it is metabolized into protoporphyrin IX (PpIX) in the course of heme synthesis. PpIX preferentially accumulates in tumor cells resulting in a red fluorescence following irradiation with violet light and the formation of singlet oxygen. This reaction, utilized to diagnose and treat cancer, is termed ALA-induced PDD and PDT. In this review, the biological significance of heme metabolites, the mechanism of PpIX accumulation in tumor cells, and the therapeutic potential of ALA-induced PDT alone and combined with hyperthermia and immunotherapy are discussed.

    DOI: 10.1016/j.intimp.2010.11.029

    PubMed

    researchmap

  • The measurement of porphyrin following administration of 5-Aminolevulinic Acid in dogs with tumor

    Osaki, T., Shun-ichiro OGURA, Takahashi, K., Tsuka, T., Imagawa, T., Okamoto, Y., Minami, S.

    13TH INTERNATIONAL PHOTODYNAMIC ASSOCIATION WORLD CONGRESS (IPA)   2011

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    researchmap

  • Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line. International journal

    Keiichi Ohshima, Kanako Inoue, Akemi Fujiwara, Keiichi Hatakeyama, Kaori Kanto, Yuko Watanabe, Koji Muramatsu, Yorikane Fukuda, Shun-ichiro Ogura, Ken Yamaguchi, Tohru Mochizuki

    PloS one   5 ( 10 )   e13247   2010.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Exosomes play a major role in cell-to-cell communication, targeting cells to transfer exosomal molecules including proteins, mRNAs, and microRNAs (miRNAs) by an endocytosis-like pathway. miRNAs are small noncoding RNA molecules on average 22 nucleotides in length that regulate numerous biological processes including cancer pathogenesis and mediate gene down-regulation by targeting mRNAs to induce RNA degradation and/or interfering with translation. Recent reports imply that miRNAs can be stably detected in circulating plasma and serum since miRNAs are packaged by exosomes to be protected from RNA degradation. Thus, profiling exosomal miRNAs are in need to clarify intercellular signaling and discover a novel disease marker as well. METHODOLOGY/PRINCIPAL FINDINGS: Exosomes were isolated from cultured cancer cell lines and their quality was validated by analyses of transmission electron microscopy and western blotting. One of the cell lines tested, a metastatic gastric cancer cell line, AZ-P7a, showed the highest RNA yield in the released exosomes and distinctive shape in morphology. In addition, RNAs were isolated from cells and culture media, and profiles of these three miRNA fractions were obtained using microarray analysis. By comparing signal intensities of microarray data and the following validation using RT-PCR analysis, we found that let-7 miRNA family was abundant in both the intracellular and extracellular fractions from AZ-P7a cells, while low metastatic AZ-521, the parental cell line of AZ-P7a, as well as other cancer cell lines showed no such propensity. CONCLUSIONS/SIGNIFICANCE: The enrichment of let-7 miRNA family in the extracellular fractions, particularly, in the exosomes from AZ-P7a cells may reflect their oncogenic characteristics including tumorigenesis and metastasis. Since let-7 miRNAs generally play a tumor-suppressive role as targeting oncogenes such as RAS and HMGA2, our results suggest that AZ-P7a cells release let-7 miRNAs via exosomes into the extracellular environment to maintain their oncogenesis.

    DOI: 10.1371/journal.pone.0013247

    PubMed

    researchmap

  • Proteome analysis of human nuclear insoluble fractions. International journal

    Hideaki Takata, Hitoshi Nishijima, Shun-Ichiro Ogura, Takehisa Sakaguchi, Paula A Bubulya, Tohru Mochizuki, Kei-Ichi Shibahara

    Genes to cells : devoted to molecular & cellular mechanisms   14 ( 8 )   975 - 90   2009.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The interphase nucleus is a highly ordered and compartmentalized organelle. Little is known regarding what elaborate mechanisms might exist to explain these properties of the nucleus. Also unresolved is whether some architectural components might facilitate the formation of functional intranuclear compartments or higher order chromatin structure. As the first step to address these questions, we performed an in-depth proteome analysis of nuclear insoluble fractions of human HeLa-S3 cells prepared by two different approaches: a high-salt/detergent/nuclease-resistant fraction and a lithium 3,5-diiodosalicylate/nuclease-resistant fraction. Proteins of the fractions were analyzed by liquid chromatography electrospray ionization tandem mass spectrometry, identifying 333 and 330 proteins from each fraction respectively. Among the insoluble nuclear proteins, we identified 37 hitherto unknown or functionally uncharacterized proteins. The RNA recognition motif, WD40 repeats, HEAT repeats and the SAP domain were often found in these identified proteins. The subcellular distribution of selected proteins, including DEK protein and SON protein, demonstrated their novel associations with nuclear insoluble materials, corroborating our MS-based analysis. This study establishes a comprehensive catalog of the nuclear insoluble proteins in human cells. Further functional analysis of the proteins identified in our study will significantly improve our understanding of the dynamic organization of the interphase nucleus.

    DOI: 10.1111/j.1365-2443.2009.01324.x

    PubMed

    researchmap

  • Proneurotensin/neuromedin N secreted from small cell lung carcinoma cell lines as a potential tumor marker. International journal

    Shun-Ichiro Ogura, Kumi Kaneko, Shoji Miyajima, Keiichi Ohshima, Ken Yamaguchi, Tohru Mochizuki

    Proteomics. Clinical applications   2 ( 12 )   1620 - 7   2008.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Proteins secreted from specific cancer cells have a high potential for use as tumor markers. We identified secreted proteins produced by 15 different carcinoma cell lines grown in serum-free medium using MS/MS. Proneurotensin/neuromedin N (proNT/NMN) was found in conditioned medium from four of seven small cell lung carcinoma cell lines but not from eight nonsmall cell lung carcinoma cell lines. These results indicate proNT/NMN has potential as a specific tumor marker of small cell lung carcinoma.

    DOI: 10.1002/prca.200800039

    PubMed

    researchmap

  • Nrf2-dependent induction of human ABC transporter ABCG2 and heme oxygenase-1 in HepG2 cells by photoactivation of porphyrins: biochemical implications for cancer cell response to photodynamic therapy. International journal

    Yuichiro Hagiya, Tatsuhiko Adachi, Shun-ichiro Ogura, Ran An, Ai Tamura, Hiroshi Nakagawa, Ichiro Okura, Tohru Mochizuki, Toshihisa Ishikawa

    Journal of experimental therapeutics & oncology   7 ( 2 )   153 - 67   2008

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Photodynamic therapy is a recently developed anticancer treatment that utilizes the generation of singlet oxygen and other reactive oxygen species in cancer tissue. Nrf2, an NF-E2-related transcription factor, plays a pivotal role in transcriptional upregulation of many target genes, including those for metabolizing enzymes and transporters essential for cellular defense in response to oxidative stress. In the present study, we examined the potential involvement of Nrf2 in the induction of human ABC transporter ABCG2 and heme oxygenase-1 (HO-1). When HepG2 cells were incubated with non-toxic concentrations of delta-aminolevulinic acid, protoporphyrin IX, or pheophorbide a and then exposed to visible light for 90 min, the mRNA level of HO-1 began increasing markedly, reaching the maximal level in 4 h. Following the transient induction of HO-1, the mRNA level of ABCG2 gradually increased in a time-dependent manner, whereas the ABCB6 mRNA level was little affected. Nrf2-specific siRNA treatments suppressed the induction of both ABCG2 and HO-1 after the photoactivation of porphyrins, suggesting that Nrf2 is a common regulator for transcriptional activation of the ABCG2 and HO-1 genes. On the other hand, the mRNA level of HO-1 was remarkably enhanced by Zn(2+)-protoporphyrin IX or hemin even in the absence of light. This induction may be attributed to inactivation of Bach1, a repressor for the HO-1 gene, by those compounds. Since patients have demonstrated individual defferences in their response to photodynamic therapy, transcriptional activation of the ABCG2 and HO-1 genes in cancer cells may affect patients' responses to photodynamic therapy.

    PubMed

    researchmap

  • Detection of epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC) using a fully automated system with a nano-scale engineered biomagnetite. International journal

    Kohei Maruyama, Haruko Takeyama, Tetsushi Mori, Keiichi Ohshima, Shun-Ichiro Ogura, Toru Mochizuki, Tadashi Matsunaga

    Biosensors & bioelectronics   22 ( 9-10 )   2282 - 8   2007.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    A fully automated system using nano-scale engineered biomagnetite was developed to detect mutations in the epidermal growth factor receptor (EGFR) gene in non-small cell lung cancer (NSCLC). Bacterial magnetic particles (BacMPs) were isolated from the magnetic bacterium Magnetospirillum magneticum AMB-1 and conjugated to streptavidin. Biotin-labeled target PCR products were then captured with the BacMPs, hybridized with the detection probe and detected by fluorescence signaling. The process was performed using a newly designed automated processor equipped with an XYZ mobile arm containing a 96-way automated pipetter, reagent dispenser and fluorescence detector. Two types of somatic mutations (in-frame deletions and point substitutions) in the EGFR gene were successfully identified within 3.5h using this system, suggesting that this system could be used in clinical tests of EGFR gene mutations in lung cancer, and potentially other cancer, patients. Additionally, a very low mutation rate could be detected in these samples.

    PubMed

    researchmap

  • Water-soluble bis(imidazolylporphyrin) self-assemblies with large two-photon absorption cross sections as potential agents for photodynamic therapy. International journal

    Kazuya Ogawa, Hideki Hasegawa, Yusuke Inaba, Yoshiaki Kobuke, Hideyuki Inouye, Yoshihiko Kanemitsu, Eiji Kohno, Toru Hirano, Shun-Ichiro Ogura, Ichiro Okura

    Journal of medicinal chemistry   49 ( 7 )   2276 - 83   2006.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Two water-soluble porphyrin self-assemblies consisting of bisacetylene- and monoacetylene-linked conjugated bis(imidazolylporphyrin) have been synthesized. Two-photon absorption (2PA) cross section values in water were determined as 7500 GM for bisacetylene- and 7900 GM for monoacetylene-linked bisporphyrin by femtosecond open-aperture Z-scan measurement. These values were almost the same as those for the similar structure reported previously in CHCl(3). Therefore, the structure is suggested to be similar in CHCl(3) and aqueous solutions. Both compounds were found to efficiently generate singlet oxygen upon one-photon irradiation in a manner similar to protoporphyrin, as demonstrated by the time-resolved luminescence measurement at the characteristic band of 1270 nm. Photocytotoxicities for HeLa cancer cells were examined and found to be as high as those of hematoporphyrin, demonstrating that these newly prepared compounds are potential candidates as 2PA-photodynamic therapy agents.

    DOI: 10.1021/jm051072+

    PubMed

    researchmap

  • Localization of poly-L-lysine-photosensitizer conjugate in nucleus. International journal

    Shun-ichiro Ogura, Keiko Yazaki, Kazuki Yamaguchi, Toshiaki Kamachi, Ichiro Okura

    Journal of controlled release : official journal of the Controlled Release Society   103 ( 1 )   1 - 6   2005.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The cellular uptake and photocytotoxity of poly-l-lysine (pL)-chlorin e6 (Ce6) conjugate were investigated. The cellularuptake of pL-Ce6 conjugate for HeLa cells was much higher than that of Ce6, and pL-Ce6 conjugate had high binding affinityfor HeLa cells. pL-Ce6 conjugate was accumulated in the nucleus of HeLa cells, and the effective photocytotoxity wasobserved by the irradiation.

    PubMed

    researchmap

  • Cellular uptake and photocytotoxicity of glycoconjugated chlorins in HeLa cells. International journal

    Shiho Hirohara, Makoto Obata, Shin-ichi Ogata, Chikara Ohtsuki, Suguru Higashida, Shun-ichiro Ogura, Ichiro Okura, Makiko Takenaka, Hiroshi Ono, Yuko Sugai, Yuji Mikata, Masao Tanihara, Shigenobu Yano

    Journal of photochemistry and photobiology. B, Biology   78 ( 1 )   7 - 15   2005.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Eight 5,10,15,20-tetrakis[3- or 4-(beta-D-glycopyranosyloxy)phenyl]chlorins were synthesized by means of the Whitlock method with diimide reduction and purified by reversed-phase thin layer chromatography (RP-TLC). All compounds were characterized by (1)H NMR spectroscopy, electron-spray ionization time-of-flight mass spectrometry (ESI-TOF MS), and UV-Vis spectroscopy. ESI-TOF MS could detect the 2H difference in molecular weight between a glycoconjugated chlorin and its corresponding porphyrin (i.e., 5,10,15,20-tetrakis[3- or 4-(beta-D-glycopyranosyloxy)phenyl]porphyrin). The cellular uptake of the eight chlorins was evaluated in HeLa cells. All glycoconjugated chlorins showed higher cellular uptake than tetraphenylporphyrin tetrasulfonic acid (TPPS), and 5,10,15,20-tetrakis[3-(beta-D-xylopyranosyloxy)phenyl]chlorin showed 50-fold higher uptake than TPPS. The photocytotoxicity of 5,10,15,20-tetrakis[3-(beta-D-glucopyranosyloxy)phenyl]chlorin, 5,10,15,20-tetrakis[3-(beta-D-xylopyranosyloxy)phenyl]chlorin and TPPS towards HeLa cells was examined at the concentration of 2x10(-7) M (mol/dm(3)). These photosensitizers had no cytotoxicity in the dark, but their photocytotoxicity decreased in the order of 5,10,15,20-tetrakis[3-(beta-D-glucopyranosyloxy)phenyl]chlorin>5,10,15,20-tetrakis[3-(beta-D-xylopyranosyloxy)phenyl]chlorin>TPPS. The results indicate that the photocytotoxicity is not related simply to cellular uptake.

    PubMed

    researchmap

  • Cellular uptake and photocytotoxicity of glycoconjugated porphyrins in HeLa cells. International journal

    Shiho Hirohara, Makoto Obata, Atsuhiro Saito, Shin-ichi Ogata, Chikara Ohtsuki, Suguru Higashida, Shun-ichiro Ogura, Ichiro Okura, Yuko Sugai, Yuji Mikata, Masao Tanihara, Shigenobu Yano

    Photochemistry and photobiology   80 ( 2 )   301 - 8   2004

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Thirty-two glycoconjugated porphyrins were synthesized by a modification of Lindsey method in the presence of Zn(OAc)(2).2H(2)O as a template. The Zn(2+) ion template strategy improved the yield about three-fold in the case of meta-substituted tetraphenylporphyrins. In addition, free-base porphyrins were obtained almost quantitatively by demetalation with 4 M HCl. Sixteen deacetylated glycoconjugated porphyrins were tested as candidate photodynamic therapy (PDT) drugs using HeLa cells. Most of the deacetylated glycoconjugated porphyrins showed higher cellular uptake than tetraphenylporphyrin tetrasulfonic acid (TPPS), and 5,10,15,20-tetrakis[4-(beta-D-arabinopyranosyloxy)phenyl]porphyrin (p-5d) in particular showed 18.5-fold higher uptake than TPPS. The photocytotoxicity of 5,10,15,20-tetrakis[4-(beta-D-glucopyranosyloxy)phenyl]porphyrin (p-5a), p-5d and TPPS was examined with HeLa cells, using a light dose of 16 J/cm(2). These photosensitizers had no cytotoxicity in the dark, but their photocytotoxicity increased in the order of TPPS < p-5a < p-5d. These results suggest p-5d is a good candidate for a PDT drug.

    PubMed

    researchmap

  • 抗腫瘍抗体結合型光増感剤を用いた光線力学治療

    小倉俊一郎

    2001.9

     More details

    Language:Japanese   Publishing type:Doctoral thesis  

    researchmap

▼display all

Research Projects

  • 5-アミノレブリン酸を用いた光力学的診断による胆道癌蛍光ナビゲーション手術の開発

    Grant number:24K11890  2024.4 - 2027.3

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    瀬尾 智, 井上 啓史, 山本 新九郎, 川西 泰広, 福原 秀雄, 小倉 俊一郎

      More details

    Grant amount:\4680000 ( Direct Cost: \3600000 、 Indirect Cost:\1080000 )

    researchmap